<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage - Adão, D - 2023 | Cochrane Library</title> <meta content="Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage - Adão, D - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013176.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage - Adão, D - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013176.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD013176.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage" name="citation_title"/> <meta content="Diego Adão" name="citation_author"/> <meta content="Universidade Federal de São Paulo" name="citation_author_institution"/> <meta content="diegoepm73@yahoo.com.br" name="citation_author_email"/> <meta content="Aecio FT Gois&lt;sup&gt;a&lt;/sup&gt;" name="citation_author"/> <meta content="Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde" name="citation_author_institution"/> <meta content="Rafael L Pacheco" name="citation_author"/> <meta content="Centro de Estudos de Saúde Baseada em Evidências e Avaliação Tecnológica em Saúde" name="citation_author_institution"/> <meta content="Carolina FMG Pimentel" name="citation_author"/> <meta content="Universidade Federal de São Paulo" name="citation_author_institution"/> <meta content="Rachel Riera" name="citation_author"/> <meta content="Cochrane Brazil" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD013176.pub2" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/02/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013176.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013176.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013176.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Endoscopy; *Erythromycin [adverse effects]; Gastrointestinal Hemorrhage [drug therapy]; *Metoclopramide; Treatment Outcome" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD013176.pub2&amp;doi=10.1002/14651858.CD013176.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="EBp84H4P";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD013176\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD013176\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","ru","th","id","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD013176.pub2",title:"Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage",firstPublishedDate:"Feb 1, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gut Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=EBp84H4P&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013176.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013176.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD013176.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD013176.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013176.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD013176.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati tinjauan sistematik&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD013176.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD013176.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD013176.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD013176.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6426 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD013176.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-sec-0115"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-sec-0043"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-sec-0101"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/appendices#CD013176-sec-0120"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/supinfo/CD013176StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/supinfo/CD013176StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/information#CD013176-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Diego Adão</a></li> <li class="author custom-tooltip" title="Deceased"><a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/information#CD013176-cr-0005">Aecio FT Gois</a><sup>a</sup></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/information#CD013176-cr-0006">Rafael L Pacheco</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/information#CD013176-cr-0007">Carolina FMG Pimentel</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD013176.pub2/information#CD013176-cr-0008">Rachel Riera</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/information/en#CD013176-sec-0130">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 February 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD013176.pub2">https://doi.org/10.1002/14651858.CD013176.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD013176-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013176-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013176-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013176-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013176-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD013176-abs-0005">ภาษาไทย</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD013176-abs-0001" lang="en"> <section id="CD013176-sec-0001"> <h3 class="title" id="CD013176-sec-0001">Background</h3> <p>Upper endoscopy is the definitive treatment for upper gastrointestinal haemorrhage (UGIH). However, up to 13% of people who undergo upper endoscopy will have incomplete visualisation of the gastric mucosa at presentation. Erythromycin acts as a motilin receptor agonist in the upper gastrointestinal (GI) tract and increases gastric emptying, which may lead to better quality of visualisation and improved treatment effectiveness. However, there is uncertainty about the benefits and harms of erythromycin in UGIH. </p> </section> <section id="CD013176-sec-0002"> <h3 class="title" id="CD013176-sec-0002">Objectives</h3> <p>To evaluate the benefits and harms of erythromycin before endoscopy in adults with acute upper gastrointestinal haemorrhage, compared with any other treatment or no treatment/placebo. </p> </section> <section id="CD013176-sec-0003"> <h3 class="title" id="CD013176-sec-0003">Search methods</h3> <p>We used standard, extensive Cochrane search methods. The latest search date was 15 October 2021. </p> </section> <section id="CD013176-sec-0004"> <h3 class="title" id="CD013176-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) that investigated erythromycin before endoscopy compared to any other treatment or no treatment/placebo before endoscopy in adults with acute UGIH. </p> </section> <section id="CD013176-sec-0005"> <h3 class="title" id="CD013176-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methods. Our primary outcomes were 1. UGIH‐related mortality and 2. serious adverse events. Our secondary outcomes were 1. all‐cause mortality, 2. visualisation of gastric mucosa, 3. non‐serious adverse events, 4. rebleeding, 5. blood transfusion, and 5. rescue invasive intervention. We used GRADE criteria to assess the certainty of the evidence for each outcome.  </p> </section> <section id="CD013176-sec-0006"> <h3 class="title" id="CD013176-sec-0006">Main results</h3> <p>We included 11 RCTs with 878 participants. The mean age ranged from 53.13 years to 64.5 years, and most participants were men (72.3%). One RCT included only non‐variceal haemorrhage, one included only variceal haemorrhage, and eight included both aetiologies. We defined short‐term outcomes as those occurring within one week of initial endoscopy. </p> <p><b>Erythromycin versus placebo</b> </p> <p>Three RCTs (255 participants) compared erythromycin with placebo. There were no UGIH‐related deaths. The evidence is very uncertain about the short‐term effects of erythromycin compared with placebo on serious adverse events (risk difference (RD) −0.01, 95% confidence interval (CI) −0.04 to 0.02; 3 studies, 255 participants; very low certainty), all‐cause mortality (RD 0.00, 95% CI −0.03 to 0.03; 3 studies, 255 participants; very low certainty), non‐serious adverse events (RD 0.01, 95% CI −0.03 to 0.05; 3 studies, 255 participants; very low certainty), and rebleeding (risk ratio (RR) 0.63, 95% CI 0.13 to 2.90; 2 studies, 195 participants; very low certainty). Erythromycin may improve gastric mucosa visualisation (mean difference (MD) 3.63 points on 16‐point ordinal scale, 95% CI 2.20 to 5.05; higher MD means better visualisation; 2 studies, 195 participants; low certainty). Erythromycin may also result in a slight reduction in blood transfusion (MD −0.44 standard units of blood, 95% CI −0.86 to −0.01; 3 studies, 255 participants; low certainty). </p> <p><b>Erythromycin plus nasogastric tube lavage versus no intervention/placebo plus nasogastric tube lavage</b> </p> <p>Six RCTs (408 participants) compared erythromycin plus nasogastric tube lavage with no intervention/placebo plus nasogastric tube lavage. There were no UGIH‐related deaths and no serious adverse events. The evidence is very uncertain about the short‐term effects of erythromycin plus nasogastric tube lavage compared with no intervention/placebo plus nasogastric tube lavage on all‐cause mortality (RD −0.02, 95% CI −0.08 to 0.03; 3 studies, 238 participants; very low certainty), visualisation of the gastric mucosa (standardised mean difference (SMD) 0.48 points on 10‐point ordinal scale, 95% CI 0.10 to 0.85; higher SMD means better visualisation; 3 studies, 170 participants; very low certainty), non‐serious adverse events (RD 0.00, 95% CI −0.05 to 0.05; 6 studies, 408 participants; very low certainty), rebleeding (RR 1.13, 95% CI 0.63 to 2.02; 1 study, 169 participants; very low certainty), and blood transfusion (MD −1.85 standard units of blood, 95% CI −4.34 to 0.64; 3 studies, 180 participants; very low certainty). </p> <p><b>Erythromycin versus nasogastric tube lavage</b> </p> <p>Four RCTs (287 participants) compared erythromycin with nasogastric tube lavage. There were no UGIH‐related deaths and no serious adverse events. The evidence is very uncertain about the short‐term effects of erythromycin compared with nasogastric tube lavage on all‐cause mortality (RD 0.02, 95% CI −0.05 to 0.08; 3 studies, 213 participants; very low certainty), visualisation of the gastric mucosa (RR 1.19, 95% CI 0.79 to 1.79; 2 studies, 198 participants; very low certainty), non‐serious adverse events (RD −0.10, 95% CI −0.34 to 0.13; 3 studies, 213 participants; very low certainty), rebleeding (RR 0.77, 95% CI 0.40 to 1.49; 1 study, 169 participants; very low certainty), and blood transfusion (median 2 standard units of blood, interquartile range 0 to 4 in both groups; 1 study, 169 participants; very low certainty). </p> <p><b>Erythromycin plus nasogastric tube lavage versus metoclopramide plus nasogastric tube lavage</b> </p> <p>One RCT (30 participants) compared erythromycin plus nasogastric tube lavage with metoclopramide plus nasogastric tube lavage. The evidence is very uncertain about the effects of erythromycin plus nasogastric tube lavage on all the reported outcomes (serious adverse events, visualisation of gastric mucosa, non‐serious adverse events, and blood transfusion). </p> </section> <section id="CD013176-sec-0007"> <h3 class="title" id="CD013176-sec-0007">Authors' conclusions</h3> <p>We are unsure if erythromycin before endoscopy in people with UGIH has any clinical benefits or harms. However, erythromycin compared with placebo may improve gastric mucosa visualisation and result in a slight reduction in blood transfusion. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD013176-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD013176-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD013176-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD013176-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD013176-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/id#CD013176-abs-0007">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD013176-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD013176-abs-0006">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD013176-abs-0003">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD013176-abs-0002" lang="en"> <h3>What are the benefits and risks of erythromycin given before endoscopy for people with intestinal bleeding? </h3> <p><b>Key messages</b> </p> <p>• Erythromycin may improve the quality of visualisation of the stomach and may also slightly reduce the need for blood transfusion. </p> <p>• Larger, well‐designed studies are needed to give better estimates of the benefits and potential harms of different doses of erythromycin in people with upper gastrointestinal bleeding. </p> <p><b>Introduction to the review topic</b> </p> <p>The upper gastrointestinal tract includes the oesophagus (food pipe), stomach, and duodenum (first part of the small intestine). People with bleeding in the upper gastrointestinal tract require endoscopy (where the doctor inserts a long, flexible tube with a light and video camera down the throat and through the oesophagus to the stomach and duodenum) to diagnose and treat the cause of the bleeding. However, it may be difficult to identify the cause of bleeding if there is food or blood in the stomach. Erythromycin is a medicine that increases contractions in the oesophagus and stomach, making the organs empty their contents faster. However, we do not know whether erythromycin, when given before upper endoscopy, is safe and effective for emptying food or blood from the stomach and improving the results of endoscopy. </p> <p><b>What did we want to find out?</b> </p> <p>We wanted to know if erythromycin was better than placebo (any dummy treatment) or other medicines to improve the following outcomes. </p> <p>• Death caused by upper gastrointestinal bleeding<br/>• Serious unwanted events<br/>• Death by any cause<br/>• Mild unwanted events<br/>• Ease of viewing the stomach during endoscopy<br/>• Rebleeding<br/>• Need for blood transfusion<br/>• Need for rescue procedure (such as surgery) </p> <p><b>What did we do?</b> </p> <p>We searched for studies that investigated the use of erythromycin compared with no treatment, placebo, or other medicines in adults with upper gastrointestinal bleeding who underwent upper endoscopy. We compared and summarised their results and rated our confidence in the evidence, based on factors such as study methods and sizes. </p> <p><b>What did we find?</b> </p> <p>We included findings from 11 studies involving 878 adults with upper gastrointestinal bleeding. Most participants were men, and the average ages ranged from 53 years to 64 years. The studies were conducted in several different countries. They compared erythromycin with placebo, lavage of the stomach with a nasogastric tube (injecting and sucking out water or saline through a tube inserted through the nose and with the tip placed inside the stomach), and metoclopramide (a medicine that speeds up the emptying of the stomach). </p> <p><b>Main results</b> </p> <p><i>Erythromycin compared with placebo</i> </p> <p>Three studies (255 people) compared erythromycin with placebo. There were no deaths related to bleeding. We do not know if erythromycin has an effect on serious unwanted events, death by any cause, mild unwanted effects, or rebleeding. Erythromycin may make it easier to see the stomach during endoscopy and may reduce blood transfusion slightly. </p> <p><i>Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage</i> </p> <p>Six studies (408 people) compared erythromycin plus nasogastric tube lavage with no treatment/placebo plus nasogastric tube lavage. There were no deaths related to bleeding and no serious unwanted events. We do not know if erythromycin plus nasogastric tube lavage compared to no treatment/placebo plus nasogastric tube lavage has an effect on death by any cause, ease of viewing the stomach, mild unwanted events, rebleeding, or blood transfusion. </p> <p><i>Erythromycin versus nasogastric tube lavage</i> </p> <p>Four studies (287 people) compared erythromycin with nasogastric tube lavage. There were no deaths related to bleeding and no severe unwanted events. We do not know if erythromycin compared with nasogastric tube lavage has any effect on death by any cause, ease of viewing the stomach, mild unwanted events, rebleeding, or blood transfusion. </p> <p><i>Erythromycin plus nasogastric tube lavage versus metoclopramide plus nasogastric tube lavage</i> </p> <p>One study (30 people) compared erythromycin plus nasogastric tube lavage with metoclopramide plus nasogastric tube lavage. We do not know if erythromycin plus nasogastric tube lavage has an effect on any of the reported outcomes.  </p> <p><b>Our conclusions</b> </p> <p>Due to a lack of solid evidence, the benefits and harms of erythromycin before endoscopy for upper gastrointestinal bleeding remain unclear. However, erythromycin compared with placebo may make it easier to see the stomach during endoscopy and may reduce blood transfusion slightly. Larger, well‐designed studies are needed to give better estimates of the benefits and potential harms of erythromycin in people with upper gastrointestinal bleeding. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>We have very little confidence in the evidence because the results varied widely across studies, and the studies involved only small numbers of people. Some reports did not clearly describe how the study was conducted, or whether the people taking part knew who had received which medicine, which could have affected the results. Further research is likely to change our results. </p> <p><b>How up to date is this evidence?</b> </p> <p>The evidence is up to date to October 2021.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD013176-sec-0115" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD013176-sec-0115"></div> <h3 class="title" id="CD013176-sec-0116">Implications for practice</h3> <section id="CD013176-sec-0116"> <p>Based on the findings of this review, there is currently a lack of high‐certainty evidence to indicate any clinical benefits or harms of erythromycin before endoscopy in people with upper gastrointestinal haemorrhage (UGIH). Compared with placebo, erythromycin may improve the quality of gastric mucosa visualisation and may also result in a slight reduction in blood transfusion. However, visualisation of the gastric mucosa is a surrogate secondary outcome assessed by non‐standardised endoscopy scoring systems, so we cannot conclude that the numerical improvement in gastric mucosa visualisation is associated with better endoscopic performance, or can provide any real benefit to people with UGIH. For all other comparisons and outcomes, the evidence is very uncertain about the benefits and harms of erythromycin. </p> <p>Our conclusions are generic because differences between studies precluded subgroup analysis. These differences were related to bleeding aetiologies (non‐variceal and variceal), settings (emergency departments and intensive care units), doses of erythromycin (in some studies together with nasogastric tube lavage), and endoscopic visibility scales. It would be useful for current practice if studies distinguished between people with non‐variceal and variceal bleeding, and did not combine erythromycin with nasogastric tube lavage. </p> <p>To facilitate informed decision‐making in clinical practice, there is a need for robust evidence on patient‐focused outcomes such as mortality, serious adverse events, rebleeding, blood transfusion, and rescue invasive intervention. </p> </section> <h3 class="title" id="CD013176-sec-0117">Implications for research</h3> <section id="CD013176-sec-0117"> <p>Further studies are required to provide higher‐certainty evidence on the effects of erythromycin administered before initial upper endoscopy. Larger trials with adequate randomisation and blinding could clarify whether this drug has any clinical benefits or harms for people with UGIH. Study investigators should separate participants with variceal and non‐variceal haemorrhage, as the pathophysiology and comorbidities differ between the two aetiologies and can influence the evaluated outcomes. Regarding comparisons, studies should focus on erythromycin versus placebo, as nasogastric tube lavage is no longer recommended. RCTs should also analyse different erythromycin doses, ideally adjusted for bodyweight, to achieve any possible benefits with the lowest possible dose, and minimise the potential risk of adverse events and bacterial selection. Investigators should objectively standardise the scale for assessing gastric mucosa visualisation. Ideally, the scale should be based on valid, objective, and reproducible data, with a gradation that correlates to clinical evaluation. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD013176-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD013176-sec-0008"></div> <div class="table" id="CD013176-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Erythromycin versus placebo for acute upper gastrointestinal haemorrhage</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Erythromycin versus placebo for acute UGIH</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with acute UGIH<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> erythromycin<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with placebo</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with erythromycin</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UGIH‐related mortality</p> <p>Assessed with: number of deaths related to UGIH</p> <p>Follow‐up: 1 week (short term)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events reported in either group. <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> did not report follow‐up duration for UGIH‐related mortality assessment. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> assessed UGIH‐related mortality within 1 week of initial endoscopy. <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> assessed UGIH‐related mortality within 24 hours of initial endoscopy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SAEs</b><br/>Assessed with: number of participants experiencing at least 1 SAE </p> <p>Follow‐up: 1 week (short term)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 100<br/>(0 to 4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD −0.01</b><br/>(−0.04 to 0.02) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> did not report follow‐up duration for SAE assessment. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> assessed SAEs within 1 week of initial endoscopy. <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> assessed SAEs during or just after initial endoscopy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Assessed with: number of deaths by any cause<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 100<br/>(3 to 9) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD 0.00</b><br/>(−0.03 to 0.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> did not report the follow‐up duration for all‐cause mortality assessment. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> assessed all‐cause mortality within 1 week of initial endoscopy. <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> assessed all‐cause mortality within 24 hours of initial endoscopy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Visualisation of gastric mucosa</b><br/>Assessed with: ordinal scale of 0–16 (higher is better) </p> <p>Follow‐up: NA</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 3.63 points higher</b><br/>(2.2 higher to 5.05 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>195<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We standardised the 2 studies that applied ordinal scales of different boundaries (0–16 in <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>, 0–8 in <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAEs</b><br/>Assessed with: number of participants experiencing at least 1 NSAE<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 100<br/>(0 to 6) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD 0.01</b><br/>(−0.03 to 0.05) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> did not report the follow‐up duration for NSAE assessment. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> reported NSAEs within 1 week of initial endoscopy. <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> reported NSAEs after intervention infusion. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rebleeding</b> <br/>Assessed with: number of participants experiencing rebleeding<br/>Follow‐up: 1 day (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 100<br/>(1 to 21) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.63</b><br/>(0.13 to 2.90) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>195<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Study authors did not report rebleeding beyond 24 hours after initial endoscopy.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Blood transfusion</b><br/>Assessed with: number of packs of red blood cells transfused (standard unit of blood)<br/>Follow‐up: 1 day (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.44 units lower</b><br/>(0.86 to 0.01 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit of measurement was standard unit of blood as defined by study authors. Only <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> reported the volume of each blood pack (250 mL–275 mL). <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> did not report follow‐up duration for blood transfusion assessment. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> and <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> did not report blood transfusion beyond 24 hours after initial endoscopy.  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>*The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>NA:</b> not applicable; <b>NSAE:</b> non‐serious adverse event; <b>RCT:</b> randomised clinical trial; <b>RD:</b> risk difference; <b>RR:</b> risk ratio; <b>SAE:</b> serious adverse event; <b>UGIH:</b> upper gastrointestinal haemorrhage. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for imprecision (no events reported in either group).<br/><sup>b</sup>Downgraded one level for risk of bias (unclear risk of attrition and reporting bias).<br/><sup>c</sup>Downgraded two levels for imprecision (very sparse data).<br/><sup>d</sup>Downgraded one level for imprecision (small sample size). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013176-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Erythromycin plus nasogastric tube lavage versus no intervention/placebo plus nasogastric tube lavage for acute upper gastrointestinal haemorrhage</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Erythromycin plus nasogastric tube lavage versus no intervention/placebo plus nasogastric tube lavage for acute UGIH</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with acute UGIH<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> erythromycin plus nasogastric tube lavage<br/><b>Comparison:</b> no intervention/placebo plus nasogastric tube lavage </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with no intervention/ placebo plus nasogastric tube lavage</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with erythromycin plus nasogastric tube lavage</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UGIH‐related mortality</p> <p>Assessed with: number of deaths related to UGIH<br/>Follow‐up: 30 days (long term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events reported in either group.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SAEs</b><br/>Assessed with: number of participants experiencing at least 1 SAE<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>408<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events reported in either group. <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed SAEs within 1 week and 30 days of initial endoscopy. 4 RCTs did not report follow‐up duration (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Assessed with: number of deaths by any cause<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3 per 100<br/>(0 to 8) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD −0.02</b><br/>(−0.08 to 0.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>238<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a> assessed all‐cause mortality within 48 hours of initial endoscopy. <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed all‐cause mortality within 1 week of initial endoscopy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Visualisation of gastric mucosa</b><br/>Assessed with: ordinal scale from 0–10 (higher is better)<br/>Follow‐up: NA </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.48 points higher</b><br/>(0.10 higher to 0.85 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Studies applied ordinal scales of different boundaries (0–3 in <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a> and <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; 0–10 in <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAEs</b><br/>Assessed with: number of participants experiencing at least one NSAE<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 100<br/>(11 to 21) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD 0.00</b><br/>(−0.05 to 0.05) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>408<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed NSAEs within 1 week and 30 days from initial endoscopy. 4 RCTs did not report follow‐up duration (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rebleeding</b><br/>Assessed with: number of participants experiencing rebleeding<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 100<br/>(13 to 40) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.13</b><br/>(0.63 to 2.02) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>169<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Blood transfusion</b><br/>Assessed with: number of packs of red blood cells transfused (standard unit of blood)<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 1.85 units lower</b><br/>(4.34 lower to 0.64 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>180<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,d,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit of measurement was a standard unit of blood as defined by study authors (no studies reported the volume of each blood pack). <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a> and <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a> assessed blood transfusion within 48 hours of initial endoscopy. <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a> assessed blood transfusion within 24 hours of initial endoscopy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>NA:</b> not applicable; <b>NSAE:</b> non‐serious adverse event; <b>RCT:</b> randomised clinical trial; <b>RD:</b> risk difference; <b>RR:</b> risk ratio; <b>SAE:</b> serious adverse event; <b>SMD:</b> standardised mean difference; <b>UGIH:</b> upper gastrointestinal haemorrhage. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for risk of bias (high risk of performance bias).<br/><sup>b</sup>Downgraded two levels for imprecision (no events reported in either group).<br/><sup>c</sup>Downgraded two levels for imprecision (very sparse data).<br/><sup>d</sup>Downgraded one level for imprecision (small sample size).<br/><sup>e</sup>Downgraded two levels for inconsistency (high heterogeneity). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013176-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Erythromycin compared to nasogastric tube lavage for acute upper gastrointestinal haemorrhage</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Erythromycin compared to nasogastric tube lavage for acute UGIH</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with acute UGIH<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> erythromycin<br/><b>Comparison:</b> nasogastric tube lavage </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with nasogastric tube lavage</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with erythromycin</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UGIH‐related mortality</p> <p>Assessed with: number of deaths related to UGIH<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events reported in either group. <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> assessed UGIH‐related mortality within one week and 30 days of initial endoscopy. <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> did not report follow‐up duration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SAEs</b><br/>Assessed with: number of participants experiencing at least 1 SAE<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>213<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events reported in either group. <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed SAEs within one week and 30 days of initial endoscopy. <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> did not report follow‐up duration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Assessed with: number of deaths by any cause<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 100<br/>(0 to 13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD 0.02</b><br/>(−0.05 to 0.08) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>213<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed all‐cause mortality within one week and 30 days of initial endoscopy. <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> did not report follow‐up duration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Visualisation of gastric mucosa</b><br/>Assessed with: number of participants scoring ≥ 6 points on an 8‐point scale </p> <p>Follow‐up: NA</p> <p> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>79 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>94 per 100 (62 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.19</b><br/>(0.79 to 1.79) </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>198<br/>(2 RCTs) </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAEs</b><br/>Assessed with: number of participants experiencing at least 1 NSAE<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>12 per 100 (0 to 35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD −0.10</b><br/>(−0.34 to 0.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>213<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c,d </sup><br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed NSAEs within one week and 30 days of initial endoscopy. <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> did not report follow‐up duration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rebleeding</b><br/>Assessed with: number of participants experiencing rebleeding<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 100<br/>(8 to 30) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.77</b><br/>(0.40 to 1.49) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>169<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Blood transfusion</b><br/>Assessed with: number of packs of red blood cells transfused (standard unit of blood)<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> <p> </p> <p> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>169</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,e</sup> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The unit of measurement was a standard unit of blood as defined by the study authors (<a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> did not report the volume of each blood pack). <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> provided only median and IQR (median 2, IQR 0–4 in the erythromycin group; median 2, IQR 0–4 in nasogastric tube lavage group). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IQR:</b> interquartile range; <b>NA:</b> not applicable; <b>NSAE:</b> non‐serious adverse event; <b>RCT:</b> randomised clinical trial; <b>RD:</b> risk difference; <b>RR:</b> risk ratio; <b>SAE:</b> serious adverse event; <b>UGIH:</b> upper gastrointestinal haemorrhage. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for risk of bias (high risk of blinding of participants and personnel, blinding of outcome assessment and selective reporting).<br/><sup>b</sup>Downgraded two levels for imprecision (no events reported in either group).<br/><sup>c</sup>Downgraded two levels for imprecision (very sparse data).<br/><sup>d</sup>Downgraded two levels for inconsistency (high heterogeneity).<br/><sup>e</sup>Downgraded one level for imprecision (small sample size). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD013176-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Erythromycin plus nasogastric tube lavage compared to metoclopramide plus nasogastric tube lavage for acute upper gastrointestinal haemorrhage</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Erythromycin plus nasogastric tube lavage compared to metoclopramide plus nasogastric tube lavage for acute UGIH</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with acute UGIH<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> erythromycin plus nasogastric tube lavage<br/><b>Comparison:</b> metoclopramide plus nasogastric tube lavage </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with metoclopramide plus nasogastric tube lavage</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with erythromycin plus nasogastric tube lavage</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UGIH‐related mortality</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies measured UGIH‐related mortality.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SAEs</b><br/>Assessed with: number of participants experiencing at least 1 SAE </p> <p>Follow‐up: not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events reported in either group. <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> did not report follow‐up duration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies measured all‐cause mortality.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Visualisation of gastric mucosa</b><br/>Assessed with: endoscopist opinion (gastric mucosa entirely visualised yes or no) </p> <p>Follow‐up: NA</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>67 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 100<br/>(57 to 100) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.30</b><br/>(0.86 to 1.96) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAEs</b><br/>Assessed with: number of participants experiencing at least 1 NSAE </p> <p>Follow‐up: not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events reported in either group. <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> did not report follow‐up duration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rebleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies measured rebleeding.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Blood transfusion</b><br/>Assessed with: number of packs of red blood cells transfused (standard unit of blood) </p> <p>Follow‐up: not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> reported a mean of 2.26 (SD not reported) units of blood transfusion in the erythromycin plus nasogastric tube lavage group and 3.66 (SD not reported) in metoclopramide plus nasogastric tube lavage group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> did not report follow‐up duration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>NA:</b> not applicable; <b>NSAE:</b> non‐serious adverse event; <b>RCT:</b> randomised clinical trial; <b>RR:</b> risk ratio; <b>SAE:</b> serious adverse event; <b>SD:</b> standard deviation; <b>UGIH:</b> upper gastrointestinal haemorrhage. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for risk of bias (unclear risk for all domains).<br/><sup>b</sup>Downgraded two levels for imprecision (no events reported in either group).<br/><sup>c</sup>Downgraded two levels for imprecision (very sparse data).<br/><sup>d</sup>Downgraded two levels for imprecision (small sample size and 95% CI not computed due to missing SDs). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD013176-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD013176-sec-0009"></div> <section id="CD013176-sec-0010"> <h3 class="title" id="CD013176-sec-0010">Description of the condition</h3> <p>Upper gastrointestinal haemorrhage (UGIH) is defined as any bleeding arising from the upper gastrointestinal (GI) tract, which comprises the oesophagus, stomach, and duodenum (<a href="./references#CD013176-bbs2-0029" title="AntunesC , Copelin EL Jr. Gastrointestinal Bleeding, Upper. Treasure Island: StatPearls Publishing, 2017.">Antunes 2017</a>). UGIH can manifest directly as external bleeding (haematemesis, melaena, or haematochezia) or indirectly as signs and symptoms of blood loss, or haemorrhagic shock syndrome (<a href="./references#CD013176-bbs2-0044" title="FallahMA , PrakashC , EdmundowiczS . Acute gastrointestinal bleeding. Medical Clinics of North America2000;84(5):1183-208.">Fallah 2000</a>; <a href="./references#CD013176-bbs2-0083" title="TarasconiA , CoccoliniF , BifflWL , TomasoniM , AnsaloniL , PicettiE , et al. Perforated and bleeding peptic ulcer: WSES guidelines. World Journal of Emergency Surgery2020;15:3.">Tarasconi 2020</a>). Episodes of UGIH can be categorised as non‐variceal or variceal, according to the aetiology of the bleeding and the presence of portal hypertension (<a href="./references#CD013176-bbs2-0073" title="PongprasobchaiS , NimitvilaiS , ChasawatJ , ManatsathitS . Upper gastrointestinal bleeding etiology score for predicting variceal and non-variceal bleeding. World Journal of Gastroenterology2009;15(9):1099-104.">Pongprasobchai 2009</a>). The most frequent aetiologies for non‐variceal UGIH are peptic ulcer, mucosal erosion, angiodysplasia, neoplasia, and Mallory‐Weiss syndrome (<a href="./references#CD013176-bbs2-0043" title="EnestvedtBK , GralnekIM , MattekN , LiebermanDA , EisenG . An evaluation of endoscopic indications and findings related to nonvariceal upper-GI hemorrhage in a large multicenter consortium. Gastrointestinal Endoscopy2008;67(3):422-9.">Enestvedt 2008</a>; <a href="./references#CD013176-bbs2-0061" title="LaineL , BarkunAN , SaltzmanJR , MartelM , LeontiadisGI . ACG clinical guideline: upper gastrointestinal and ulcer bleeding. American Journal of Gastroenterology2021;116(5):899-917.">Laine 2021</a>). In variceal UGIH (i.e. bleeding related to portal hypertension), the most common aetiologies are oesophagogastric varices and portal hypertensive gastropathy (<a href="./references#CD013176-bbs2-0065" title="LylesT , ElliottA , RockeyDC . A risk scoring system to predict in-hospital mortality in patients with cirrhosis presenting with upper gastrointestinal bleeding. Journal of Clinical Gastroenterology2014;48(8):712-20.">Lyles 2014</a>). </p> <p>The incidence of UGIH ranges from 36 to 172 per 100,000 inhabitants per year, and UGIH‐related mortality ranges from 1% to 3% (<a href="./references#CD013176-bbs2-0054" title="HreinssonJP , KalaitzakisE , GudmundssonS , BjörnssonES . Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting. Scandinavian Journal of Gastroenterology2013;48(4):439-47.">Hreinsson 2013</a>). Variceal haemorrhage is less common than non‐variceal haemorrhage (25% versus 75%) but has a higher mortality rate (15% versus 3%; <a href="./references#CD013176-bbs2-0062" title="LanasA , García-RodríguezLA , Polo-TomásM , PonceM , Alonso-AbreuI , Perez-AisaMA , et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. American Journal of Gastroenterology2009;104(7):1633-41.">Lanas 2009</a>; <a href="./references#CD013176-bbs2-0069" title="NahonS , HagègeH , LatriveJP , RosaI , NaletB , BourB , et al. Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter study. Endoscopy2012;44(11):998-1008.">Nahon 2012</a>). </p> <p>Upper endoscopy is the procedure of choice to control bleeding after initial management of UGIH (<a href="./references#CD013176-bbs2-0040" title="deFranchisR , BoschJ , Garcia-TsaoG , ReibergerT , RipollC , Baveno VII Faculty. Baveno VII – Renewing consensus in portal hypertension. Journal of Hepatology2022;76(4):959-74.">de Franchis 2022</a>; <a href="./references#CD013176-bbs2-0059" title="LaineL , McQuaidKR . Endoscopic therapy for bleeding ulcers: an evidence based approach based on meta-analyses of randomized controlled trials. Clinical Gastroenterology and Hepatology2009;7:33-47.">Laine 2009</a>). However, up to 13% of people who undergo endoscopy will present an incomplete visualisation of the gastric mucosa, and 41% of second‐look endoscopies will not result in a diagnosis (<a href="./references#CD013176-bbs2-0081" title="StollmanNH , PutchaRV , NeustaterBR , TagleM , RaskinJB , RogersAI . The uncleared fundal pool in acute upper gastrointestinal bleeding: implications and outcomes. Gastrointestinal Endoscopy1997;46(4):324-7.">Stollman 1997</a>). Waiting until physiological emptying of the stomach is not recommended: this approach can lead to worse outcomes, and delayed upper endoscopy (after more than 24 hours) is not cost‐effective (<a href="./references#CD013176-bbs2-0028" title="AnanthakrishnanAN , McGinleyEL , SaeianK . Outcomes of weekend admissions for upper gastrointestinal hemorrhage: a nationwide analysis. Clinical Gastroenterology and Hepatology2009;7:296-302e1.">Ananthakrishnan 2009</a>; <a href="./references#CD013176-bbs2-0038" title="CooperGS , ChakA , Connors AF Jr, HarperDL , RosenthalGE . The effectiveness of early endoscopy for upper gastrointestinal hemorrhage: a community-based analysis. Medical Care1998;36:462-74.">Cooper 1998</a>; <a href="./references#CD013176-bbs2-0039" title="CooperGS , ChakA , WayLE , HammarPJ , HarperDL , RosenthalGE . Early endoscopy in upper gastrointestinal hemorrhage: associations with recurrent bleeding, surgery, and length of hospital stay. Gastrointestinal Endoscopy1999;49(2):145-52.">Cooper 1999</a>; <a href="./references#CD013176-bbs2-0063" title="LauJY , YuY , TangRS , ChanHC , YipHC , ChanSM , et al. Timing of endoscopy for acute upper gastrointestinal bleeding. New England Journal of Medicine2020;382(14):1299-308.">Lau 2020</a>; <a href="./references#CD013176-bbs2-0089" title="WysockiJD , SrivastavS , WinsteadNS . A nationwide analysis of risk factors for mortality and time to endoscopy in upper gastrointestinal haemorrhage. Alimentary Pharmacology and Therapeutics2012;36(1):30-6.">Wysocki 2012</a>). Furthermore, failure to diagnose blood clots by initial endoscopy is associated with higher morbidity and mortality (<a href="./references#CD013176-bbs2-0036" title="ChengCL , LeeCS , LiuNJ , ChenPC , ChiuCT , WuCS . Overlooked lesions at emergency endoscopy for acute nonvariceal upper gastrointestinal bleeding. Endoscopy2002;34(7):527-30.">Cheng 2002</a>; <a href="./references#CD013176-bbs2-0081" title="StollmanNH , PutchaRV , NeustaterBR , TagleM , RaskinJB , RogersAI . The uncleared fundal pool in acute upper gastrointestinal bleeding: implications and outcomes. Gastrointestinal Endoscopy1997;46(4):324-7.">Stollman 1997</a>). Gastric lavage, a traditional and accessible option to clean the stomach, may lead to pulmonary aspiration, owing to the presence of the tube in the lower oesophageal sphincter (keeping it partially open) and the high intragastric pressures caused by the infusion of a large volume of fluid for lavage (<a href="./references#CD013176-bbs2-0064" title="LeeSD , KearneyDJ . A randomized controlled trial of gastric lavage prior to endoscopy for acute upper gastrointestinal bleeding. Journal of Clinical Gastroenterology2004;38(10):861-5.">Lee 2004</a>; <a href="./references#CD013176-bbs2-0088" title="ValeJA , KuligK , American Academy of Clinical Toxicology, European Association of Poisons Centres and Clinical Toxicologists. Position paper: gastric lavage. Clinical Toxicology2004;42(7):933-43.">Vale 2004</a>). There is a need for a safe and effective measure for optimising gastric visualisation during upper endoscopy in people with UGIH. </p> <p>See <a href="./appendices#CD013176-sec-0121">Appendix 1</a> for a glossary of terms. </p> </section> <section id="CD013176-sec-0011"> <h3 class="title" id="CD013176-sec-0011">Description of the intervention</h3> <p>Erythromycin (Ilotycin), a macrolide antibiotic, was discovered by McGuire and colleagues in 1952 (<a href="./references#CD013176-bbs2-0068" title="McGuireJM , BunchRL , AndersonRC , BoazHE , FlynnEH , PowellHM , et al. Ilotycin, a new antibiotic. Antibiotics &amp; Chemotherapy1952;2(6):281-3.">McGuire 1952</a>). It is obtained from the metabolic products of <i>Saccharopolyspora erythraea</i> (<a href="./references#CD013176-bbs2-0071" title="OliynykM , SamborskyyM , LesterJB , MironenkoT , ScottN , DickensS , et al. Complete genome sequence of the erythromycin-producing bacterium Saccharopolyspora erythraea NRRL23338. Nature Biotechnology2007;25(4):447-53.">Oliynyk 2007</a>), and is used to treat aerobic Gram‐positive bacilli and cocci infections worldwide (<a href="./references#CD013176-bbs2-0057" title="JelićD , AntolovićR . From erythromycin to azithromycin and new potential ribosome-binding antimicrobials. Antibiotics2016;5(3):E29.">Jelić 2016</a>). Erythromycin has two main presentations: oral, in the form of base and esters of erythromycin (stearate, estolate, and ethylsuccinate), and parenteral, in the form of lactobionate (<a href="./references#CD013176-bbs2-0072" title="ParsonsRL , DavidJA , RaymondK , StampSM . Pharmacokinetics of intravenous erythromycin lactobionate. Journal of International Medical Research1980;8(Suppl 2):15-23.">Parsons 1980</a>; <a href="./references#CD013176-bbs2-0085" title="TjandramagaTB , Van HeckenA , MullieA , VerbesseltR , De SchepperPJ , VerbistL , et al. Relative bioavailability of enteric coated pellets, stearate and ethylsuccinate formulations of erythromycin. Pharmacology1984;29(6):305-11.">Tjandramaga 1984</a>). The serum elimination half‐life of erythromycin is around 1.5 hours, with high levels of metabolites concentration in the liver and bile excretion (<a href="./references#CD013176-bbs2-0046" title="GlanzerS , PulidoSA , TutzS , WagnerGE , KriechbaumM , GubensäkN , et al. Structural and functional implications of the interaction between macrolide antibiotics and bile acids. Chemistry2015;21(11):4350-8.">Glanzer 2015</a>). Only 5% of oral erythromycin is excreted in urine (<a href="./references#CD013176-bbs2-0058" title="JosefssonK , BerganT , MagniL . Dose-related pharmacokinetics after oral administration of a new formulation of erythromycin base. British Journal of Clinical Pharmacology1982;13(5):685-91.">Josefsson 1982</a>). </p> <p>Studies have shown adverse effects of erythromycin besides bacteriostatic effects (<a href="./references#CD013176-bbs2-0033" title="BoydI . Erythromycin-induced hearing loss. Lancet1991;337(8733):113.">Boyd 1991</a>; <a href="./references#CD013176-bbs2-0049" title="HaefeliWE , SchoenenbergerRA , WeissP , RitzR . Possible risk for cardiac arrhythmia related to intravenous erythromycin. Intensive Care Medicine1992;18:469-73.">Haefeli 1992</a>; <a href="./references#CD013176-bbs2-0075" title="RayWA , MurrayKT , MeredithS , NarasimhuluSS , HallK , SteinCM . Oral erythromycin and the risk of sudden death from cardiac causes. New England Journal of Medicine2004;351(11):1089-96.">Ray 2004</a>). Most of these additional adverse effects involve the GI tract (nausea, vomiting, abdominal cramps, and diarrhoea; <a href="./references#CD013176-bbs2-0034" title="CatnachSM , FaircloughPD . Erythromycin and the gut. Gut1992;33(3):397-401.">Catnach 1992</a>), and mainly occur after parenteral administration of the drug (<a href="./references#CD013176-bbs2-0032" title="BowlerWA , HostettlerC , SamuelsonD , LavinBS , Oldfield EC 3rd. Gastrointestinal side effects of intravenous erythromycin: incidence and reduction with prolonged infusion time and glycopyrrolate pretreatment. American Journal of Medicine1992;92(3):249-53.">Bowler 1992</a>; <a href="./references#CD013176-bbs2-0041" title="DowneyKM , Chaput de SaintongeDM . Gastrointestinal side effects after intravenous erythromycin lactobionate. British Journal of Clinical Pharmacology1986;21(3):295-9.">Downey 1986</a>; <a href="./references#CD013176-bbs2-0045" title="GholsonCF , WarrenGH . Fulminant hepatic failure associated with intravenous erythromycin lactobionate. Archives of Internal Medicine1990;150(1):215-6.">Gholson 1990</a>; <a href="./references#CD013176-bbs2-0080" title="SeifertCF , SwaneyRJ , Bellanger-McCleeryRA . Intravenous erythromycin lactobionate-induced severe nausea and vomiting. Annals of Pharmacotherapy1989;23(1):40-4.">Seifert 1989</a>). On the other hand, some known GI effects have been used favourably to improve clinical conditions such as diabetic gastroparesis (<a href="./references#CD013176-bbs2-0056" title="JanssensJ , PeetersTL , VantrappenG , TackJ , UrbainJL , De RooM , et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. New England Journal of Medicine1990;322(15):1028-31.">Janssens 1990</a>; <a href="./references#CD013176-bbs2-0087" title="UrbainJL , VantrappenG , JanssensJ , Van CutsemE , PeetersT , De RooM . Intravenous erythromycin dramatically accelerates gastric emptying in gastroparesis diabeticorum and normals and abolishes the emptying discrimination between solids and liquids. Journal of Nuclear Medicine1990;31:1490-3.">Urbain 1990</a>), and feed intolerance in critically ill individuals (<a href="./references#CD013176-bbs2-0035" title="ChapmanMJ , FraserRJ , KlugerMT , BuistMD , De NichiloDJ . Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding. Critical Care Medicine2000;28:2334-7.">Chapman 2000</a>; <a href="./references#CD013176-bbs2-0050" title="HawkyardCV , KoernerRJ . The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks. Journal of Antimicrobial Chemotherapy2007;59:347-58.">Hawkyard 2007</a>; <a href="./references#CD013176-bbs2-0066" title="MacLarenR , KiserTH , FishDN , WischmeyerPE . Erythromycin vs metoclopramide for facilitating gastric emptying and tolerance to intragastric nutrition in critically ill patients. Journal of Parenteral and Enteral Nutrition2008;32(4):412-9.">MacLaren 2008</a>; <a href="./references#CD013176-bbs2-0070" title="NguyenNQ , ChapmanMJ , FraserRJ , BryantLK , HollowayRH . Erythromycin is more effective than metoclopramide in the treatment of feed intolerance in critical illness. Critical Care Medicine2007;35(2):483-9.">Nguyen 2007</a>). GI effects of erythromycin are observed from parenteral doses of 70 mg (<a href="./references#CD013176-bbs2-0077" title="RitzMA , ChapmanMJ , FraserRJ , FinnisME , ButlerRN , CmielewskiP . Erythromycin dose of 70 mg accelerates gastric emptying as effectively as 200 mg in the critically ill. Intensive Care Medicine2005;31:949-54.">Ritz 2005</a>).  </p> </section> <section id="CD013176-sec-0012"> <h3 class="title" id="CD013176-sec-0012">How the intervention might work</h3> <p>Erythromycin acts as a motilin receptor agonist in the upper GI tract (<a href="./references#CD013176-bbs2-0079" title="SangerGJ , WangY , HobsonA , BroadJ . Motilin: towards a new understanding of the gastrointestinal neuropharmacology and therapeutic use of motilin receptor agonists. British Journal of Pharmacology2013;170(7):1323-32.">Sanger 2013</a>). Motilin is a 22‐amino acid peptide found in the M and enterochromaffin cells that amplifies phase III of the migrating motor complex of the gut (<a href="./references#CD013176-bbs2-0078" title="SangerGJ . Motilin receptor neuropharmacology: revised understanding. Current Opinion in Pharmacology2012;12(6):641-6.">Sanger 2012</a>). Through this mechanism, erythromycin promotes a potent contractile action over the upper GI tract, increasing lower oesophageal pressure and gastric emptying. This effect is observed from 15 to 30 minutes after parenteral drug administration, both in animals (<a href="./references#CD013176-bbs2-0055" title="ItohZ , NakayaM , SuzukiT , AraiH , WakabayashiK . Erythromycin mimics exogenous motilin in gastrointestinal contractile activity in the dog. American Journal of Physiology1984;247:G688-94.">Itoh 1984</a>), and in humans (<a href="./references#CD013176-bbs2-0067" title="MantidesA , XynosE , ChrysosE , GeorgopoulosN , VassilakisJS . The effect of erythromycin in gastric emptying of solids and hypertonic liquids in healthy subjects. American Journal of Gastroenterology1993;88:198-202.">Mantides 1993</a>; <a href="./references#CD013176-bbs2-0086" title="TzovarasG , XynosE , ChrysosE , MantidesA , VassilakisJS . The effect of intravenous erythromycin on esophageal motility in healthy subjects. American Journal of Surgery1996;171(3):316-9.">Tzovaras 1996</a>). </p> <p>There is evidence to suggest that nasogastric tube lavage may help to clear the stomach in people with UGIH (<a href="./references#CD013176-bbs2-0064" title="LeeSD , KearneyDJ . A randomized controlled trial of gastric lavage prior to endoscopy for acute upper gastrointestinal bleeding. Journal of Clinical Gastroenterology2004;38(10):861-5.">Lee 2004</a>). Due to the similar stomach‐emptying effect of erythromycin, administration of this antibiotic, alone or together with gastric lavage, could improve gastric mucosa visibility and endoscopy performance. </p> </section> <section id="CD013176-sec-0013"> <h3 class="title" id="CD013176-sec-0013">Why it is important to do this review</h3> <p>Our justification for this review was based on the following facts.</p> <p> <ul id="CD013176-list-0001"> <li> <p>UGIH is a prevalent disease with high morbidity and mortality.</p> </li> <li> <p>Erythromycin has a documented fast and potent effect on the upper GI tract, emptying the stomach. </p> </li> <li> <p>Improved gastric visualisation would improve endoscopic treatment and promote earlier discharge, saving resources. </p> </li> <li> <p>To date, no Cochrane Review has analysed the effects of erythromycin before initial upper endoscopy in people with UGIH. </p> </li> </ul> </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD013176-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD013176-sec-0014"></div> <p>To evaluate the benefits and harms of erythromycin before endoscopy in adults with acute upper gastrointestinal haemorrhage, compared with any other treatment or no treatment/placebo. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD013176-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD013176-sec-0015"></div> <section id="CD013176-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD013176-sec-0017"> <h4 class="title">Types of studies</h4> <p>We included only randomised controlled trials (RCTs). We considered RCTs with parallel design (cross‐over design is not plausible for this clinical situation) and with individual‐ and cluster‐level randomisation. We considered studies published as full‐text articles and as abstract only, regardless of date or language of publication, and studies with no published data. </p> </section> <section id="CD013176-sec-0018"> <h4 class="title">Types of participants</h4> <p>Eligible studies enrolled people aged 16 years or older with acute UGIH (confirmed or suspected, regardless of aetiology or severity) who were referred for upper endoscopy. </p> </section> <section id="CD013176-sec-0019"> <h4 class="title">Types of interventions</h4> <p>We included studies comparing erythromycin administered before upper endoscopy, with or without nasogastric lavage, at any dose, route, or scheme of administration, to any of the following controls. </p> <p> <ul id="CD013176-list-0002"> <li> <p>No intervention/placebo</p> </li> <li> <p>Nasogastric tube lavage only</p> </li> <li> <p>Another prokinetic drug (e.g. metoclopramide)</p> </li> <li> <p>Different doses, routes of administration, or schemes of erythromycin.</p> </li> </ul> </p> </section> <section id="CD013176-sec-0020"> <h4 class="title">Types of outcome measures</h4> <p>We assessed all outcomes in the short term (within one week of initial endoscopy) and in the long term (more than one week after initial endoscopy), except visualisation of gastric mucosa, which is always concomitant with the initial endoscopy. </p> <p>Where studies measured outcomes at short‐term and long‐term follow‐up, we reported both in the main text and included only the short‐term outcome data in the summary of findings tables, as short‐term data may better represent the effects of a single dose of erythromycin. If any study reported our outcomes at more than one time point within short‐term or long‐term follow‐up, we used the last time point. </p> <p>Reporting of our predefined outcomes was not an inclusion criterion for the review.</p> <section id="CD013176-sec-0021"> <h5 class="title">Primary outcomes</h5> <p>Our selection of primary outcomes was based on an international consensus conference (<a href="./references#CD013176-bbs2-0060" title="LaineL , SpiegelB , RostomA , MoayyediP , KuipersEJ , BardouM , et al. Methodology for randomized trials of patients with nonvariceal upper gastrointestinal bleeding: recommendations from an international consensus conference. American Journal of Gastroenterology2010;105(3):540-50.">Laine 2010</a>), identified by the COMET (Core Outcome Measures in Effectiveness Trials) initiative (<a href="./references#CD013176-bbs2-0037" title="COMET Initiative. Core outcome measures in effectiveness trials initiative. comet-initiative.org (accessed 8 February 2018).">COMET</a>).  </p> <p> <ul id="CD013176-list-0003"> <li> <p>UGIH‐related mortality, defined as the number of deaths related to UGIH, including hypovolaemic shock, transfusion reaction, spontaneous bacterial peritonitis, and pulmonary aspiration </p> </li> <li> <p>Serious adverse events, defined as the number of participants with: at least one event that increased risk of death, required or prolonged hospitalisation, or resulted in persistent or significant disability; or any important and potentially harmful clinical event </p> </li> </ul> </p> </section> <section id="CD013176-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD013176-list-0004"> <li> <p>All‐cause mortality, defined as the number of deaths from any cause</p> </li> <li> <p>Visualisation of gastric mucosa, assessed through any validated tool or endoscopist opinion </p> </li> <li> <p>Non‐serious adverse events, defined as the number of participants with any undesirable event not considered a serious adverse event </p> </li> <li> <p>Rebleeding, defined as the number of participants presenting at least one new episode of UGIH confirmed by endoscopy after resolution of the initial episode </p> </li> <li> <p>Blood transfusion, defined as the number of packs of red blood cells received by each participant </p> </li> <li> <p>Rescue invasive intervention, defined as the number of participants undergoing any invasive intervention to control bleeding after endoscopic treatment failure (e.g. surgery, vascular embolisation, gastro‐oesophageal balloon, transjugular intrahepatic portosystemic shunt (TIPS)) </p> </li> </ul> </p> </section> </section> </section> <section id="CD013176-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD013176-sec-0024"> <h4 class="title">Electronic searches</h4> <p>We conducted a literature search to identify all published and unpublished RCTs, placing no restrictions on the language of publication. We translated non‐English language papers as necessary and fully assessed them. We searched the following electronic databases. </p> <p> <ul id="CD013176-list-0005"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; Issue 10 of 12, 2021; via the Cochrane Library; <a href="./appendices#CD013176-sec-0122">Appendix 2</a>) </p> </li> <li> <p>MEDLINE (1966 to 15 October 2021; via Ovid; <a href="./appendices#CD013176-sec-0123">Appendix 3</a>) </p> </li> <li> <p>Embase (1988 to 15 October 2021; via Ovid; <a href="./appendices#CD013176-sec-0124">Appendix 4</a>) </p> </li> <li> <p>Cumulative Index to Nursing and Allied Health Literature (CINAHL; 1982 to 15 October 2021; via EBSCO Health; <a href="./appendices#CD013176-sec-0125">Appendix 5</a>) </p> </li> <li> <p>Latin American and Caribbean Health Sciences Literature database (LILACS; 1982 to 15 October 2021; via Biblioteca Virtual em Saúde (BVS); <a href="./appendices#CD013176-sec-0126">Appendix 6</a>) </p> </li> </ul> </p> </section> <section id="CD013176-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We checked the reference lists of all primary studies and reviewed articles for additional references. We contacted authors of identified studies and enquired as to other published and unpublished studies. We also contacted manufacturers and experts in the field. </p> <p>We searched for retraction and erratum notices related to included articles on PubMed and reported the date of the notices in the review (<a href="http://www.ncbi.nlm.nih.gov/pubmed" target="_blank">www.ncbi.nlm.nih.gov/pubmed</a>). </p> <section id="CD013176-sec-0026"> <h5 class="title">Grey literature databases</h5> <p>We searched the following grey literature databases on 15 October 2021 (<a href="./appendices#CD013176-sec-0127">Appendix 7</a>). </p> <p> <ul id="CD013176-list-0006"> <li> <p>Health Management Information Consortium (HMIC) database (<a href="http://www.ovid.com/site/catalog/DataBase/99.jsp" target="_blank">ovid.com/site/catalog/DataBase/99.jsp</a>) </p> </li> <li> <p>National Technical Information Service (NTIS) database (<a href="https://ntrl.ntis.gov/NTRL/" target="_blank">ntrl.ntis.gov/NTRL/</a>) </p> </li> <li> <p>OpenGrey (<a href="http://www.opengrey.eu" target="_blank">opengrey.eu</a>) </p> </li> </ul> </p> </section> <section id="CD013176-sec-0027"> <h5 class="title">Clinical trials registers and trial result registers</h5> <p>We also searched the following clinical trials registers on 15 October 2021 (<a href="./appendices#CD013176-sec-0127">Appendix 7</a>). </p> <p> <ul id="CD013176-list-0007"> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>) </p> </li> <li> <p>Current Controlled Trials metaRegister of Controlled Trials (mRCT; <a href="http://www.isrctn.com/mrct" target="_blank">isrctn.com/mrct</a>) </p> </li> <li> <p>EU Clinical Trials Register (<a href="http://www.clinicaltrialsregister.eu/" target="_blank">www.clinicaltrialsregister.eu/</a>) </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (WHO ICTRP; <a href="http://www.who.int/trialsearch" target="_blank">www.who.int/trialsearch</a>) </p> </li> </ul> </p> </section> </section> </section> <section id="CD013176-sec-0028"> <h3 class="title" id="CD013176-sec-0028">Data collection and analysis</h3> <section id="CD013176-sec-0029"> <h4 class="title">Selection of studies</h4> <p>Two review authors (DA and CP) independently screened titles and abstracts of all the studies identified by the search and coded them as 'retrieve' (eligible or potentially eligible) or 'do not retrieve' (clearly ineligible). Two review authors (DA and CP) independently screened the full texts, identified studies for inclusion, and identified and recorded reasons for exclusion of ineligible studies. They resolved any disagreements through discussion or by consulting a third review author (RP) if necessary. We identified and excluded duplicates and collated multiple reports of the same study so that each study, rather than each report, was the unit of interest in the review. We recorded the selection process in sufficient detail to complete a PRISMA flow diagram (<a href="#CD013176-fig-0001">Figure 1</a>) and the <a href="./references#CD013176-sec-0136" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD013176-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD013176-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD013176-sec-0030"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (DA and CP) independently extracted the following study characteristics and outcome data to a standard data collection form that we had piloted on at least one study in the review. </p> <p> <ul id="CD013176-list-0008"> <li> <p>Methods: study design, total duration of study and run‐in, number of study centres and location, study setting, withdrawals, and date of study </p> </li> <li> <p>Participants: number randomised, mean age, age range, sex, severity of the condition, diagnostic criteria, and inclusion and exclusion criteria </p> </li> <li> <p>Interventions: intervention, comparison, concomitant medications, and excluded medications</p> </li> <li> <p>Outcomes: primary and secondary outcomes specified and collected, and time points reported </p> </li> <li> <p>Notes: funding for the study, and notable conflicts of interest of study authors</p> </li> </ul> </p> <p>We noted in the <a href="./references#CD013176-sec-0136" title="">Characteristics of included studies</a> table if outcome data were reported in an unusable way. We resolved any disagreements by consensus or by involving a third review author (AG). One review author (DA) entered the data from the data collection form into Review Manager Web (<a href="./references#CD013176-bbs2-0076" title="Review Manager Web (RevMan Web). Version 1.22.0. The Cochrane Collaboration, 2020. Available at revman.cochrane.org.">RevMan Web 2020</a>). We double‐checked that the data were entered correctly by comparing the study reports with the presentation of data in the systematic review. A second review author (CP) spot‐checked study characteristics for accuracy against the study report. </p> </section> <section id="CD013176-sec-0031"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (DA and RP) independently assessed the risk of bias for each included study using the Cochrane risk of bias tool (RoB 1; <a href="./references#CD013176-bbs2-0052" title="HigginsJP , AltmanDG , SterneJA , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). We resolved any disagreements by discussion or by involving a third review author (RR). We assessed risk of bias according to the following domains. </p> <p> <ul id="CD013176-list-0009"> <li> <p>Random sequence generation</p> </li> <li> <p>Allocation concealment</p> </li> <li> <p>Blinding of participants and personnel</p> </li> <li> <p>Blinding of outcome assessment</p> </li> <li> <p>Incomplete outcome data</p> </li> <li> <p>Selective outcome reporting</p> </li> <li> <p>Other bias</p> </li> </ul> </p> <p>We rated each potential source of bias as high, low, or unclear, and provided a quote from the study report to justify our judgement in a risk of bias table. We summarised the risk of bias judgements across studies for each of the domains listed. For the domains 'Blinding of participants and personnel', 'Blinding of outcome assessment', and 'Incomplete outcome data', we assessed the risk of bias at outcome level. For all other domains, we assessed risk of bias at study level. Where information on risk of bias related to unpublished data or correspondence with a study author, we noted this in the risk of bias table. When considering treatment effects, we considered the risk of bias for the studies that contribute to that outcome as part of the GRADE assessment. </p> </section> <section id="CD013176-sec-0032"> <h4 class="title">Assessment of bias in conducting the systematic review</h4> <p>We conducted the review according to the published protocol and reported any deviations from it (with reasons) in the <a href="#CD013176-sec-0134">Differences between protocol and review</a> section of the systematic review (<a href="./references#CD013176-bbs2-0091" title="SilvaDA , RieraR , PachecoRL , PimentelCF , GoisAF . Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage. Cochrane Database of Systematic Reviews2018, Issue 11. Art. No: CD013176. [DOI: 10.1002/14651858.CD013176]">Silva 2018</a>). </p> </section> <section id="CD013176-sec-0033"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed dichotomous data as risk ratios (RRs) and continuous data as mean difference (MDs) or standardised mean difference (SMDs). We tried to ensure that higher scores had the same meaning for all continuous outcomes; where this was not possible, we explained the change of direction for readers of the review. </p> <p>We undertook meta‐analyses only where this was meaningful (i.e. where the treatments, participants, and the underlying clinical question were sufficiently similar for pooling to make sense). We used risk differences (RDs) instead of RRs for meta‐analyses that contained at least one study with no events in both arms, because the Mantel‐Haenszel method with RRs would automatically discard this type of study (<a href="./references#CD013176-bbs2-0090" title="XuC , Furuya-KanamoriL , ZorzelaL , LinL , VohraS . A proposed framework to guide evidence synthesis practice for meta-analysis with zero-events studies. Journal of Clinical Epidemiology2021;135:70-8.">Xu 2021</a>). </p> <p>A common way for study authors to indicate they have skewed data is to report medians and interquartile ranges (IQRs). Where we encountered this, we noted that the data were skewed and considered the implication; we did not meta‐analyse studies with skewed data but provided a narrative summary instead. </p> <p>Where studies had multiple study arms, we included only the relevant arms. If any study had entered two relevant comparisons (e.g. drug A versus placebo and drug B versus placebo) into the same meta‐analysis, we would have halved the control group to avoid double counting. </p> </section> <section id="CD013176-sec-0034"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the individual participant. If we had included any cluster‐RCTs, we would have calculated the design effect based on intracluster correlation as recommended in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD013176-bbs2-0053" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>). </p> </section> <section id="CD013176-sec-0035"> <h4 class="title">Dealing with missing data</h4> <p>We contacted study authors or study sponsors to verify key study characteristics and to obtain missing numerical outcome data as necessary (e.g. for studies published as abstracts only). If we were unable to obtain the relevant information, we did not impute missing data. When studies provided medians and IQRs rather than means and standard deviations (SDs), we presented the data narratively and conducted no meta‐analysis. </p> </section> <section id="CD013176-sec-0036"> <h4 class="title">Assessment of heterogeneity</h4> <p>First, we visually examined the forest plots to determine whether the confidence intervals (CIs) had good overlap, which would suggest low or no statistical heterogeneity (inconsistency) between RCTs. We then assessed the presence of statistical heterogeneity using the Chi<sup>2</sup> test (significant if P &lt; 0.1), and quantified statistical heterogeneity using the I<sup>2</sup> statistic, applying the following interpretations (<a href="./references#CD013176-bbs2-0051" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60.">Higgins 2003</a>; <a href="./references#CD013176-bbs2-0053" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>). </p> <p> <ul id="CD013176-list-0010"> <li> <p>0% to 40%: might not be important</p> </li> <li> <p>30% to 60%: may represent moderate heterogeneity</p> </li> <li> <p>50% to 90%: may represent substantial heterogeneity</p> </li> <li> <p>75% to 100%: considerable heterogeneity</p> </li> </ul> </p> <p>We explored the causes of heterogeneity through prespecified subgroup analysis (<a href="./references#CD013176-bbs2-0053" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>). </p> </section> <section id="CD013176-sec-0037"> <h4 class="title">Assessment of reporting biases</h4> <p>If we include 10 or more studies in future updates, we will create and examine a funnel plot to explore possible publication bias and use Egger's test to determine the statistical significance of the reporting bias, considering a P value below 0.05 representative of statistical significance (<a href="./references#CD013176-bbs2-0042" title="EggerM , SmithGD , SchneiderM , MinderC . Bias in meta-analysis detected by a simple, graphical test. BMJ1997;315(7109):629-34.">Egger 1997</a>). </p> </section> <section id="CD013176-sec-0038"> <h4 class="title">Data synthesis</h4> <p>We used the random‐effects model by default. To test the robustness of our findings, we conducted a sensitivity analysis for primary outcomes using a fixed‐effect model (<a href="#CD013176-sec-0040">Sensitivity analysis</a>). In case of divergence between the two models, we presented both results; otherwise, we presented only results from the random‐effects model. </p> </section> <section id="CD013176-sec-0039"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned the following subgroup analyses for the primary outcomes.</p> <p> <ul id="CD013176-list-0011"> <li> <p>Variceal and non‐variceal UGIH (participants with variceal haemorrhage expected to have worse outcomes) </p> </li> <li> <p>Age (participants aged 60 years or older expected to have worse outcomes)</p> </li> <li> <p>Presence of coronary artery disease (participants with coronary artery disease expected to have worse outcomes) </p> </li> <li> <p>Different doses of erythromycin (higher doses expected to lead to better outcomes)</p> </li> </ul> </p> <p>We tested subgroup differences using the formal test provided in Review Manager Web (<a href="./references#CD013176-bbs2-0076" title="Review Manager Web (RevMan Web). Version 1.22.0. The Cochrane Collaboration, 2020. Available at revman.cochrane.org.">RevMan Web 2020</a>). </p> </section> <section id="CD013176-sec-0040"> <h4 class="title">Sensitivity analysis</h4> <p>To assess the robustness of our conclusions, we planned the following sensitivity analyses for the primary outcomes. </p> <p> <ul id="CD013176-list-0012"> <li> <p>Excluding studies judged at high or unclear risk of selection or detection bias</p> </li> <li> <p>Excluding studies where the sponsor played a role in the design or conduct of the trial </p> </li> <li> <p>Excluding unpublished results</p> </li> <li> <p>Repeating the analyses with the fixed‐effect model (<a href="#CD013176-sec-0038">Data synthesis</a>) </p> </li> </ul> </p> <section id="CD013176-sec-0041"> <h5 class="title">Reaching conclusions</h5> <p>We based our conclusions on the quantitative or narrative synthesis of studies included in this review. We avoided making recommendations for practice; our implications for research gave the reader a clear sense of the needed focus of future research and remaining uncertainties in the field. </p> </section> </section> <section id="CD013176-sec-0042"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We created summary of findings tables for the following outcomes (<a href="./full#CD013176-tbl-0001">summary of findings Table 1</a>; <a href="./full#CD013176-tbl-0002">summary of findings Table 2</a>; <a href="./full#CD013176-tbl-0003">summary of findings Table 3</a>; <a href="./full#CD013176-tbl-0004">summary of findings Table 4</a>). </p> <p> <ul id="CD013176-list-0013"> <li> <p>UGIH‐related mortality</p> </li> <li> <p>Serious adverse events</p> </li> <li> <p>All‐cause mortality</p> </li> <li> <p>Visualisation of gastric mucosa</p> </li> <li> <p>Non‐serious adverse events</p> </li> <li> <p>Rebleeding</p> </li> <li> <p>Blood transfusion</p> </li> </ul> </p> <p>We created one summary of findings table for each comparison. Two review authors (DA and RP) independently assessed the certainty of the body of evidence and reached a consensus view on any downgrading decisions. We resolved any disagreements by discussion or by involving a third review author (RR). </p> <p>Where studies reported an outcome at both short‐term and long‐term follow‐up, we included only the short‐term data, as they may be more representative of the effects of a single dose of erythromycin. </p> <p>For the outcome 'Visualisation of gastric mucosa', we chose to report data measured by the most objective method (e.g. between a scoring system using an objective numerical scale versus the subjective opinion of an endoscopist, we chose the numerical scale). </p> <p>We used the five GRADE considerations (study limitations, consistency of effect, imprecision, indirectness, and publication bias) to assess the certainty of the body of evidence derived from studies that contributed data to each short‐term outcome. We classified the certainty of the evidence as high, moderate, low, or very low, using the methods and recommendations described in the <i>Cochrane Handbook</i> for <i>Systematic Reviews of Interventions</i> (<a href="./references#CD013176-bbs2-0053" title="HigginsJP , ThomasJ , ChandlerJ , CumpstonM , LiT , PageMJ , WelchVA , editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (updated February 2021). Cochrane, 2021. Available from training.cochrane.org/handbook/archive/v6.2.">Higgins 2021</a>), and employing GRADEpro GDT software (<a href="./references#CD013176-bbs2-0047" title="GRADEpro GDT. Version accessed 15 December 2021. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. Available at gradepro.org.">GRADEpro GDT</a>). We justified all decisions to downgrade or upgrade the certainty of the evidence in the footnotes and provided comments to aid the reader's understanding where necessary. We considered whether there was additional outcome information that was not incorporated into the meta‐analyses, noted this in the comments, and stated if it supported or contradicted the information from the meta‐analyses. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD013176-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD013176-sec-0043"></div> <section id="CD013176-sec-0044"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD013176-sec-0136" title="">Characteristics of included studies</a> and <a href="./references#CD013176-sec-0137" title="">Characteristics of excluded studies</a>. </p> <section id="CD013176-sec-0045"> <h4 class="title">Results of the search</h4> <p>The search strategy retrieved 859 records, of which 22 were duplicates. We screened the titles and abstracts of the 837 remaining records, discarding 810 that were clearly irrelevant. We performed a full‐text assessment of 27 reports, excluding 13 and including 14. The included reports were from 11 RCTs, one of which had four publications. <a href="#CD013176-fig-0001">Figure 1</a> shows the flow diagram of the study identification and selection process. </p> <p>We also identified one study awaiting classification (<a href="./references#CD013176-bbs2-0025" title="RudzkiS , CzekalowskiS , MichalakK , KuszW , FularzA . Erythromycin improves quality of endoscopy for acute upper gastrointestinal bleeding [Erytromycyna jako czynnik poprawiajacy jakość badania endoskopowego w ostrych krwawieniach z górnego odcinka przewodu pokarmowego]. Wiadomości Lekarskie2006;59:490-1. ">Rudzki 2006</a>; <a href="./references#CD013176-sec-0138" title="">Characteristics of studies awaiting classification</a>) and two ongoing studies (<a href="./references#CD013176-bbs2-0026" title="EudraCT2016-003339-39. Azithromycin versus erythromycin before endoscopy in upper gastrointestinal bleeding [A randomized, controlled and double-blind trial of intravenous azithromycin versus intravenous erythromycin as a single dose prior to endoscopy in upper gastrointestinal bleeding]. www.clinicaltrialsregister.eu/ctr-search/trial/2016-003339-39/ES (first received 7 April 2017). ">EudraCT2016‐003339‐39</a>; <a href="./references#CD013176-bbs2-0027" title="NCT01716572. Erythromycin versus gastric lavage to improve quality of endoscopy in patients with upper gastrointestinal bleeding [Erythromycin versus gastric lavage to improve quality of endoscopic examination in patients with upper gastrointestinal bleeding. A prospective randomized trial]. clinicaltrials.gov/ct2/show/NCT01716572 (first received 30 October 2012). ">NCT01716572</a>; <a href="./references#CD013176-sec-0139" title="">Characteristics of ongoing studies</a>). </p> </section> <section id="CD013176-sec-0046"> <h4 class="title">Included studies</h4> <p>The <a href="./references#CD013176-sec-0136" title="">Characteristics of included studies</a> table provides full details of the 11 included studies (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). We contacted the authors of all studies for additional information, but only one author replied to our questions (<a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>). </p> <section id="CD013176-sec-0047"> <h5 class="title">Design</h5> <p>The studies were parallel‐group RCTs published between 1996 and 2020.</p> </section> <section id="CD013176-sec-0048"> <h5 class="title">Sample size</h5> <p>The studies randomised 878 participants in total (60 in <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>, 102 in <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>, 40 in <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>, 100 in <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>, 41 in <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>, 105 in <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>, 74 in <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>, 45 in <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>, 43 in <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>, 253 in <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>, and 15 in <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>), and analysed 865 participants at latest follow‐up (60 in <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; 90 in <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>, 40 in <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>, 99 in <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>, 41 in <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>, 105 in <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>, 74 in <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>, 45 in <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>, 43 in <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>, 253 in <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>, and 15 in <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). </p> <p>Thirteen participants were randomised then excluded: 12 participants in <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> did not meet the inclusion criterion 'bleeding of variceal aetiology' (participants with cirrhosis were excluded after upper endoscopy revealed bleeding of non‐variceal aetiology), and one participant in <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a> needed palliative care for advanced liver cancer diagnosed after randomisation. </p> </section> <section id="CD013176-sec-0049"> <h5 class="title">Settings</h5> <p>Four RCTs were conducted in Europe (<a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>, <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>, and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> in France; and <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> in Switzerland), four were conducted in Asia (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> in Pakistan, <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> in Saudi Arabia, <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a> in Iran, and <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> in Korea), and two were conducted in North America (<a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> and <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> in the USA). <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a> (abstract) did not describe the study setting. All RCTs were published in English. </p> </section> <section id="CD013176-sec-0050"> <h5 class="title">Participants</h5> <section id="CD013176-sec-0051"> <h6 class="title">Diagnosis of UGIH</h6> <p>All studies included people with UGIH. Seven RCTs diagnosed UGIH based on direct clinical signs (haematemesis, melaena, or both; <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>), and <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a> diagnosed UGIH based on direct or indirect clinical signs (haematemesis, melaena, acute anaemia requiring active resuscitation, or a combination of these). <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a> used nasogastric tube lavage to identify bleeding in the stomach and anaemia. Two RCTs did not report UGIH diagnosis criteria (<a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). </p> </section> <section id="CD013176-sec-0052"> <h6 class="title">Age</h6> <p>The mean age of participants ranged from 53.13 years to 64.5 years. Most participants were men (72.3%). Two RCTs did not provide this information (<a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>). </p> </section> <section id="CD013176-sec-0053"> <h6 class="title">Bleeding duration</h6> <p>The maximum time interval from bleeding onset to inclusion in the study was 12 hours. Five RCTs did not report this interval (<a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). </p> </section> <section id="CD013176-sec-0054"> <h6 class="title">Aetiology of haemorrhage</h6> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> included only non‐variceal haemorrhage, <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> included only variceal haemorrhage, and eight RCTs included non‐variceal and variceal haemorrhage (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>), although <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a> did not specify the culprit lesion for its three cirrhotic participants. <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a> provided no information about aetiology. Overall, the RCTs included 204 (23.5%) participants with non‐variceal haemorrhage, 211 (24.3%) participants with variceal haemorrhage, and 450 (52.0%) participants with unknown aetiology in the final analysis. </p> </section> </section> <section id="CD013176-sec-0055"> <h5 class="title">Interventions and comparators</h5> <p>The RCTs evaluated the following comparisons.</p> <p> <ul id="CD013176-list-0014"> <li> <p>Erythromycin versus placebo: three RCTs (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>) </p> </li> <li> <p>Erythromycin plus nasogastric tube lavage versus no intervention/placebo plus nasogastric tube lavage: six RCTs (versus no intervention in <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>, <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>, <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>, and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; versus placebo in <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a> and <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>) </p> </li> <li> <p>Erythromycin versus nasogastric tube lavage: four RCTs (<a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>) </p> </li> <li> <p>Erythromycin plus nasogastric tube lavage versus metoclopramide plus nasogastric tube lavage: one RCT (<a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>) </p> </li> </ul> </p> <p>Six RCTs used a 250 mg fixed dose of parenteral erythromycin (<a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>), while <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> used a 125 mg fixed parenteral dose. Two RCTs (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>) used a weight‐adjusted parenteral dose (3 mg/kg). <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> did not report the parenteral dose. <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> was the only study to use oral erythromycin (500 mg fixed dose). </p> <p>The time from intervention (drug infusion or ingestion) to upper endoscopy was 20 minutes in <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>, 30 minutes in four RCTs (<a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>), 20 to 60 minutes in <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>, 30 to 60 minutes in <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>, 60 minutes in <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>, 60 to 120 minutes in <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>, and 180 minutes in <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>. <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> waited 15 minutes from nasogastric tube lavage to endoscopy, and <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> did not report the time from intervention to endoscopy, but all other RCTs with a control intervention used the same delay for erythromycin and for control. </p> <p>Of the RCTs that used a placebo control, three used normal saline (<a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>), and two did not describe the placebo in the report (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>). </p> <p>Regarding the administration of nasogastric tube lavage, seven studies performed lavage after randomisation (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a> did not explicitly state this, but reported that lavage took place "as part of the clinical evaluation". No RCTs described standard procedures or measures (form of washing, washing fluid, or volume). </p> <p>The numbers of participants randomised to the various interventions were as follows.</p> <p> <ul id="CD013176-list-0015"> <li> <p>Erythromycin only: 275 (31.3%) participants (500 mg oral: 30 participants; 250 mg parenteral: 192 participants; 125 mg parenteral: 53 participants) </p> </li> <li> <p>Nasogastric tube lavage only: 168 (19.1%) participants</p> </li> <li> <p>Erythromycin plus nasogastric tube lavage: 202 (23.0%) participants (250 mg parenteral: 148 participants; 3 mg/kg parenteral: 39 participants; unknown dose: 15 participants) </p> </li> <li> <p>Metoclopramide plus nasogastric tube lavage: 15 (1.7%) participants</p> </li> <li> <p>Placebo/no intervention plus nasogastric tube lavage: 85 (9.6%) participants</p> </li> <li> <p>Placebo only: 133 (15.1%) participants</p> </li> </ul> </p> </section> <section id="CD013176-sec-0056"> <h5 class="title">Outcomes</h5> <p>The RCTs evaluated the following outcomes of interest.</p> <p> <ul id="CD013176-list-0016"> <li> <p>UGIH‐related mortality: five RCTs (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). </p> </li> <li> <p>Serious adverse events: 10 RCTs (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>) </p> </li> <li> <p>All‐cause mortality: eight RCTs (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>) </p> </li> <li> <p>Visualisation of gastric mucosa: all 11 RCTs. The studies assessed this outcome using different numerical scores (<a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>), or dichotomous criteria based on endoscopist judgement (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>) </p> </li> <li> <p>Non‐serious adverse events: 10 RCTs (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>) </p> </li> <li> <p>Rebleeding: four RCTs (<a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). No studies reported precise criteria for defining rebleeding. </p> </li> <li> <p>Blood transfusion: all 11 RCTs. Only <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> specified (by email) the volume of packed red blood cells (250 mL to 275 mL). No RCT reported the need for other blood components, such as plasma or platelets. </p> </li> <li> <p>Rescue invasive intervention: four RCTs (<a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>). <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a> assessed the need for emergency surgery but did not describe what type of surgery was performed, or whether it was performed before or after an endoscopic mechanical attempt to control bleeding. <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> also assessed the need for emergency surgery (bleeding ulcer), in all cases after endoscopy revealed a quantity of blood in the stomach that warranted immediate surgery, without a prior endoscopic mechanical attempt to control bleeding (endoscopic treatment failure related to impossibility to locate the source of bleeding). <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> assessed angiographic embolisation as a rescue invasive intervention for a gastric ulcer with spurting bleeding after an endoscopic mechanical attempt to control bleeding (endoscopic treatment failure related to persistent bleeding after prior source control). </p> </li> </ul> </p> </section> </section> <section id="CD013176-sec-0057"> <h4 class="title">Excluded studies</h4> <p>We excluded 13 reports for the following reasons.</p> <p> <ul id="CD013176-list-0017"> <li> <p>Five letters (<a href="./references#CD013176-bbs2-0012" title="AubertinJM , LevoirD , BecheurH , BlochF , PetiteJP . Value of intravenous erythromycin before gastroscopy in the upper digestive hemorrhage [lntérêt de l 'érythromycine intra-veineuse avant gastroscopie dans les hémorragies digestives hautes]. Gastroenterologie Clinique et Biologique1995;19:645-6. ">Aubertin 1995</a>; <a href="./references#CD013176-bbs2-0013" title="DaramSR , GarretsonR . Erythromycin is preferable to metoclopramide as a prokinetic in acute upper GI bleeding. Gastrointestinal Endoscopy2011;74(1):234. ">Daram 2011</a>; <a href="./references#CD013176-bbs2-0014" title="DasA . Should erythromycin be administered before endoscopy for acute upper gastrointestinal hemorrhage?Nature Clinical Practice. Gastroenterology &amp; Hepatology2008;5(7):358-9. ">Das 2008</a>; <a href="./references#CD013176-bbs2-0020" title="LawrenceSP , McNallyPR . Intravenous erythromycin to clear the stomach of obstructing clot. Gastrointestinal Endoscopy1994;40(6):774-5. ">Lawrence 1994</a>; <a href="./references#CD013176-bbs2-0022" title="NionI , AndantC , JouetP , LeportJ , SouléJC . Role of intravenous erythromycin in the preparation for endoscopy in case of upper digestive hemorrhage [lntérêt de l'érythromycine intraveineuse dans la préparation à l'endoscopie en cas d'hémorragie digestive haute]. Gastroentérologie Clinique et Biologique1998;22(5):554-5. ">Nion 1998</a>) </p> </li> <li> <p>Five narrative reviews (<a href="./references#CD013176-bbs2-0015" title="EbellMH . Predicting the risk of bleeding in patients taking warfarin. American Family Physician2010;81(6):780. ">Ebell 2010</a>; <a href="./references#CD013176-bbs2-0017" title="FergusonCB , MitchellRM . Non-variceal upper gastrointestinal bleeding. Ulster Medical Journal2006;75(1):32-9. ">Ferguson 2006</a>; <a href="./references#CD013176-bbs2-0018" title="KhamaysiI , GralnekIM . Nonvariceal upper gastrointestinal bleeding: timing of endoscopy and ways to improve endoscopic visualization. Gastrointestinal Endoscopy Clinics of North America2015;25(3):443-8. ">Khamaysi 2015</a>; <a href="./references#CD013176-bbs2-0019" title="KimS , MuthusamyVR . Prophylactic erythromycin in acute upper gastrointestinal bleeding: moving forward in improving endoscopic efficacy. Saudi Journal of Gastroenterology2013;19(5):193-4. ">Kim 2013</a>; <a href="./references#CD013176-bbs2-0024" title="Sanchez-YagueA , KaltenbachT , YamamotoH , AnglemyerA , InoueH , SoetiknoR . The endoscopic cap that can (with videos). Gastrointestinal Endoscopy2012;76(1):169-78. ">Sanchez‐Yague 2012</a>) </p> </li> <li> <p>Two studies interrupted early with no available data (<a href="./references#CD013176-bbs2-0016" title="EUCTR2010-024309-11-ES. Eritromicina versus lavados por sonda nasogástrica para mejorar la calidad visual de la endoscopia digestiva en pacientes con hemorragia digestiva alta. Ensayo clínico aleatorizado. www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2010-024309-11 (first received 27 December 2010). ">EudraCT2010‐024309‐11</a>; <a href="./references#CD013176-bbs2-0021" title="NCT02017379. Randomized control trial comparing prokinetics and their influence on endoscopy outcomes for upper GI bleed. clinicaltrials.gov/ct2/show/NCT02017379 (first received 20 December 2013). ">NCT02017379</a>) </p> </li> <li> <p>One duplicated translation from <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a> (<a href="./references#CD013176-bbs2-0023" title="RotondanoG , MarmoR . Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study [L’infusione di eritromicina migliora la qualità della EGDS in pazienti con emorragia digestiva superiore: uno studio randomizzato controllato]. Giornale Italiano di Endoscopia Digestiva2003;26:117-9. ">Rotondano 2003</a>) </p> </li> </ul> </p> </section> </section> <section id="CD013176-sec-0058"> <h3 class="title">Risk of bias in included studies</h3> <p>We used RoB 1 to assess risk of bias, classifying studies as being at low risk, high risk or unclear risk for each domain (<a href="./references#CD013176-bbs2-0052" title="HigginsJP , AltmanDG , SterneJA , editor(s). Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). We contacted the first or senior authors of all 11 studies to request additional methodological details not reported in the article. One study author responded to our requests and provided additional information (<a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>). See the <a href="./references#CD013176-sec-0136" title="">Characteristics of included studies</a>, <a href="#CD013176-fig-0002">Figure 2</a>, and <a href="#CD013176-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD013176-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013176-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD013176-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study. Empty spaces mean the study did not assess the outcome." data-id="CD013176-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. Empty spaces mean the study did not assess the outcome. </p> </div> </div> </div> <section id="CD013176-sec-0059"> <h4 class="title">Allocation</h4> <p>Five RCTs reported adequate methods of random sequence generation and allocation concealment so were at low risk of selection bias (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). Six RCTs did not provide sufficient information to assess random sequence generation and allocation concealment so were at unclear risk (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). </p> </section> <section id="CD013176-sec-0060"> <h4 class="title">Blinding</h4> <p>Four RCTs reported that participants, personnel, and outcome assessors were blinded so were at low risk of performance and detection bias (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>). <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a> did not provide sufficient information to assess blinding (unclear risk), except for assessment of the outcome 'All‐cause mortality' (low risk). <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a> and <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> reported no attempt to blind participants, personnel, or outcome assessors (high risk), except for assessment of the outcomes 'All‐cause mortality' and 'Visualisation of gastric mucosa' (low risk). <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a> reported no attempt to blind participants, personnel, or outcome assessors for most outcomes (high risk), and did not provide enough information to assess blinding of outcome assessors for the outcome 'Blood transfusion' (unclear risk). <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> did not provide enough information to assess blinding (unclear risk). <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> reported no attempt to blind participants and personnel (high risk), did not provide sufficient information to assess blinding of outcome assessors (unclear risk), except for the outcomes 'All‐cause mortality' (low risk) and 'Visualisation of gastric mucosa' (high risk). <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> reported no attempt to blind participants and personnel (high risk), and did not provide sufficient information to assess the blinding of outcome assessors (unclear risk), except for the outcomes 'All‐cause mortality' (low risk) and 'Visualisation of gastric mucosa' (low risk).  </p> </section> <section id="CD013176-sec-0061"> <h4 class="title">Incomplete outcome data</h4> <p>Seven RCTs reported balanced numbers across intervention groups and no important losses to follow‐up so were at low risk of attrition bias (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). Four RCTs did not provide sufficient information to assess incomplete outcome data so were at unclear risk (<a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). </p> </section> <section id="CD013176-sec-0062"> <h4 class="title">Selective reporting</h4> <p>The methods section of <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> stated that the investigators would evaluate the endpoints 'number of transfused blood units', 'instances of rebleeding', and 'mortality ratings' at seven days and 30 days; however, the results section only presented data collected at one time point, without specifying if it was seven days or 30 days (high risk). <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> registered the RCT retrospectively, and the study authors did not report all planned outcomes (high risk). The remaining nine studies did not provide sufficient information to assess reporting bias so were at unclear risk (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). </p> </section> <section id="CD013176-sec-0063"> <h4 class="title">Other potential sources of bias</h4> <p>Five RCTs had no other potential sources of bias so were at low risk of bias in this domain (<a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). Four RCTs did not provide sufficient information to assess other potential sources of bias so were at unclear risk (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a> presented baseline imbalance (high risk). <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> presented baseline imbalance, but we are uncertain to what extent this may have impacted the outcomes (unclear risk). </p> </section> </section> <section id="CD013176-sec-0064"> <h3 class="title" id="CD013176-sec-0064">Effects of interventions</h3> <p>See: <a href="./full#CD013176-tbl-0001"><b>Summary of findings 1</b> Erythromycin versus placebo for acute upper gastrointestinal haemorrhage</a>; <a href="./full#CD013176-tbl-0002"><b>Summary of findings 2</b> Erythromycin plus nasogastric tube lavage versus no intervention/placebo plus nasogastric tube lavage for acute upper gastrointestinal haemorrhage</a>; <a href="./full#CD013176-tbl-0003"><b>Summary of findings 3</b> Erythromycin compared to nasogastric tube lavage for acute upper gastrointestinal haemorrhage</a>; <a href="./full#CD013176-tbl-0004"><b>Summary of findings 4</b> Erythromycin plus nasogastric tube lavage compared to metoclopramide plus nasogastric tube lavage for acute upper gastrointestinal haemorrhage</a> </p> <section id="CD013176-sec-0065"> <h4 class="title">Comparison 1: Erythromycin versus placebo</h4> <p>Three RCTs, totaling 255 participants, compared erythromycin with placebo (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>). </p> <section id="CD013176-sec-0066"> <h5 class="title">UGIH‐related mortality</h5> <p>The following three RCTs (255 participants) addressed UGIH‐related mortality and reported no events in either group (very low‐certainty evidence). </p> <p> <ul id="CD013176-list-0018"> <li> <p><a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>: 0/30 events in the erythromycin group versus 0/30 in the placebo group (follow‐up duration not defined) </p> </li> <li> <p><a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>: 0/47 events in the erythromycin group versus 0/43 in the placebo group, within one week of initial endoscopy (data provided by email) </p> </li> <li> <p><a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>: 0/51 events in the erythromycin group versus 0/54 in the placebo group, within 24 hours of initial endoscopy </p> </li> </ul> </p> <p>There were no data regarding long‐term UGIH‐related mortality (more than one week after initial endoscopy). </p> <p>We did not perform subgroup analysis because meta‐analysis was not possible for this outcome. Only <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> presented separate data for participants with non‐variceal and variceal UGIH, and only <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> administered a low dose of erythromycin; there were no events reported in either group (0/47 in the erythromycin group versus 0/43 in the placebo group) in the short term (within one week of initial endoscopy). </p> <p>We did not perform sensitivity analysis because meta‐analysis was not possible for this outcome. </p> </section> <section id="CD013176-sec-0067"> <h5 class="title">Serious adverse events</h5> <p>Three RCTs addressed serious adverse events (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>). <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> reported 0/30 events in both groups without specifying the follow‐up duration; we regarded the zero events as short‐term follow‐up outcome data. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> reported 0/47 events in the erythromycin group versus 2/43 events (aspiration pneumonia) in the placebo group, within one week of initial endoscopy. <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> reported no events in either group (0/51 in the erythromycin group versus 0/54 in the placebo group), during or just after initial endoscopy. The evidence is very uncertain about the effect of erythromycin compared to placebo on serious adverse events (erythromycin 0%, placebo 1.57%; RD −0.01, 95% CI −0.04 to 0.02; I<sup>2</sup> = 0%; 3 studies, 255 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0004" title="">Analysis 1.1</a>). </p> <p>We did not perform subgroup analysis because only one RCT contributed to the number of events. Only <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> provided separate data for participants with non‐variceal and variceal UGIH, and only <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> administered a low dose of erythromycin; there were 0/47 events in the erythromycin group and 2/47 events (aspiration pneumonia) in the placebo group within one week of initial endoscopy (RR 0.18, 95% CI 0.01 to 3.71; 1 study, 90 participants). </p> <p>We did not perform sensitivity analysis because only one RCT contributed to the number of events. </p> </section> <section id="CD013176-sec-0068"> <h5 class="title">All‐cause mortality</h5> <p>Three RCTs addressed all‐cause mortality (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>). <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> reported 0/30 events in both groups, but did not report the follow‐up duration for this outcome. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> reported 4/47 events in the erythromycin group and 6/43 events in the placebo group, within one week of initial endoscopy (in‐hospital mortality). <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> reported 0/51 events in the erythromycin group versus 0/54 events in the placebo group within 24 hours of initial endoscopy. The evidence is very uncertain about the effect of erythromycin compared to placebo on all‐cause mortality (erythromycin 3.12%, placebo 4.72%; RD 0.00, 95% CI −0.03 to 0.03; I<sup>2</sup> = 0%; 3 studies, 255 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0005" title="">Analysis 1.2</a>). </p> <p><a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> also reported two events in the long term (more than one week after initial endoscopy) but did not specify which group these participants belonged to. </p> </section> <section id="CD013176-sec-0069"> <h5 class="title">Visualisation of gastric mucosa</h5> <p>Three RCTs assessed visualisation of gastric mucosa (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>). </p> <p><a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> and <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> provided continuous data for this outcome. <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> used an 8‐point scale, where a higher score indicated a clearer stomach. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> expanded this scoring system to a 16‐point scale. Through a simple arithmetic transformation, we were able to combine data from the two studies in a meta‐analysis. Erythromycin may improve visualisation of gastric mucosa (MD 3.63, 95% CI 2.20 to 5.05; higher MD means better visualisation; I<sup>2</sup> = 62%; 2 studies, 195 participants; low‐certainty evidence; <a href="./references#CD013176-fig-0006" title="">Analysis 1.3</a>). </p> <p><a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>, <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>, and <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> provided dichotomous data for this outcome. <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> and <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> used cutoff points on ordinal scales to classify the stomach as empty or not empty (5 or more points on a 7‐point scale in <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; 15 or more points on a 16‐point scale in <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>). Meta‐analysis of these data favoured erythromycin (erythromycin 62.33%, placebo 30.13%; RR 2.09, 95% CI 1.44 to 3.03; I<sup>2</sup> = 0%; 2 studies, 150 participants; <a href="./references#CD013176-fig-0007" title="">Analysis 1.4</a>). <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> reported the judgement of the endoscopist, who decided whether each participant had an empty stomach (endoscopy was easy to perform and less than 25% of the gastric mucosa was covered by blood). This was the case for 42/51 participants in the erythromycin group and 18/54 participants in the placebo group (erythromycin 80.76%, placebo 33.33%; RR 2.47, 95% CI 1.66 to 3.68; 1 study, 105 participants; <a href="./references#CD013176-fig-0007" title="">Analysis 1.4</a>); </p> </section> <section id="CD013176-sec-0070"> <h5 class="title">Non‐serious adverse events</h5> <p>Three RCTs assessed non‐serious adverse events (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>). <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> reported 0/30 events in both groups, but did not report the follow‐up duration for this outcome. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> reported 0/51 events in the erythromycin group versus 0/54 in the placebo group, within one week of initial endoscopy. <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> reported four events (three urgent bowel movements, one moderate abdominal cramps) in the erythromycin group (4/51) and one event (headache) in the placebo group (1/54), after intervention infusion.  </p> <p>The evidence is very uncertain about the effect of erythromycin compared with placebo on non‐serious adverse events (erythromycin 3.12%, placebo 0.78%; RD 0.01, 95% CI −0.03 to 0.05; I<sup>2</sup> = 23%; 3 studies, 255 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0008" title="">Analysis 1.5</a>). </p> </section> <section id="CD013176-sec-0071"> <h5 class="title">Rebleeding</h5> <p>Two RCTs assessed rebleeding within 24 hours of initial endoscopy (<a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>). The evidence is very uncertain about the effect of erythromycin compared with placebo on rebleeding (erythromycin 4.08%, placebo 7.21%; RR 0.63, 95% CI 0.13 to 2.90; I<sup>2</sup> = 23%; 2 studies, 195 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0009" title="">Analysis 1.6</a>). Neither study reported this outcome beyond 24 hours after initial endoscopy. </p> </section> <section id="CD013176-sec-0072"> <h5 class="title">Blood transfusion</h5> <p>Three RCTs assessed the need for blood transfusion (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>). The unit of measurement was a standard unit of blood, as defined by the study authors. Only <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> stated the volume of each blood pack (250 mL to 275 mL). <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> did not report the follow‐up duration for this outcome. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> and <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> did not report this outcome beyond 24 hours after the initial endoscopy. Erythromycin may result in a slight reduction in blood transfusion (MD −0.44 standard units of blood, 95% CI −0.86 to −0.01; I<sup>2</sup> = 0%; 3 studies, 255 participants; low‐certainty evidence; <a href="./references#CD013176-fig-0010" title="">Analysis 1.7</a>). </p> </section> <section id="CD013176-sec-0073"> <h5 class="title">Rescue invasive intervention</h5> <p>Two RCTs assessed rescue invasive intervention (<a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>). <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> reported 0/51 events in the erythromycin group versus 0/54 in the placebo group. <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> reported 3/51 events in the erythromycin group versus 1/54 in the placebo group; in both groups, the outcome was immediate surgery after failed initial endoscopy because of a bleeding ulcer. <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> did not report the follow‐up duration for this outcome. Meta‐analysis of these data showed no difference between erythromycin and placebo (erythromycin 3.06%, placebo 1.03%; RD 0.01, 95% CI −0.03 to 0.06; I<sup>2</sup> = 20%; 2 studies, 195 participants; <a href="./references#CD013176-fig-0011" title="">Analysis 1.8</a>). </p> </section> </section> <section id="CD013176-sec-0074"> <h4 class="title">Comparison 2: Erythromycin plus nasogastric tube lavage versus no intervention/placebo plus nasogastric tube lavage </h4> <p>Six RCTs, totaling 408 participants, compared erythromycin plus nasogastric tube lavage with no intervention/placebo plus nasogastric tube lavage (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). </p> <section id="CD013176-sec-0075"> <h5 class="title">UGIH‐related mortality</h5> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> addressed UGIH‐related mortality and reported 0/14 events in the erythromycin plus nasogastric tube lavage group versus 0/15 in the no intervention plus nasogastric tube lavage group (very low‐certainty evidence) within one week and 30 days of initial endoscopy. </p> <p>It was not possible to perform sensitivity or subgroup analysis for this outcome. <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> included only participants with non‐variceal UGIH. </p> </section> <section id="CD013176-sec-0076"> <h5 class="title">Serious adverse events</h5> <p>The following six RCTs (408 participants) addressed serious adverse events and reported no events in either group (very low‐certainty evidence). </p> <p> <ul id="CD013176-list-0019"> <li> <p><a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>: 0/20 in the erythromycin plus nasogastric tube lavage group versus 0/20 in the placebo plus nasogastric tube lavage group </p> </li> <li> <p><a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>: 0/49 in the erythromycin plus nasogastric tube lavage group versus 0/50 in the placebo plus nasogastric tube lavage group </p> </li> <li> <p><a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>: 0/19 in the erythromycin plus nasogastric tube lavage group versus 0/22 in no intervention plus nasogastric tube lavage group </p> </li> <li> <p><a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>: 0/15 in the erythromycin plus nasogastric tube lavage group versus 0/15 in the placebo plus nasogastric tube lavage group </p> </li> <li> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>: 0/14 in the erythromycin plus nasogastric tube lavage group versus 0/15 in no intervention plus nasogastric tube lavage group </p> </li> <li> <p><a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>: 0/84 in the erythromycin plus nasogastric tube lavage group versus 0/85 in no intervention plus nasogastric tube lavage group </p> </li> </ul> </p> <p>Two RTCs assessed serious adverse events within one week and 30 days of initial endoscopy (<a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). Four RCTs did not report the follow‐up duration for this outcome (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>). </p> <p>We did not perform sensitivity or subgroup analysis because meta‐analysis was not possible for this outcome. Only <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> defined the aetiology of the haemorrhage, and included only participants with non‐variceal UGIH. </p> </section> <section id="CD013176-sec-0077"> <h5 class="title">All‐cause mortality</h5> <p>Four RCTs addressed all‐cause mortality (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). </p> <p>Three RCTs addressed this outcome in the short term (within one week of initial endoscopy); short‐time follow‐up duration was 48 hours in <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a> and one week in <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). The evidence is very uncertain about the effect of erythromycin plus nasogastric tube lavage compared with no intervention/placebo plus nasogastric tube lavage on all‐cause mortality in the short term (erythromycin 2.54%, control 5.0%; RD −0.02, 95% CI −0.08 to 0.03; I<sup>2</sup> = 0%; 3 studies, 238 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0012" title="">Analysis 2.1</a>); </p> <p>Two RCTs addressed this outcome in the long term (within 30 days of initial endoscopy; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). The evidence is very uncertain about the effect of erythromycin plus nasogastric tube lavage on all‐cause mortality in the long term (erythromycin 3.06%, no intervention 9.0%; RD −0.05, 95% CI −0.12 to 0.01; I<sup>2</sup> = 0%; 2 studies,198 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0012" title="">Analysis 2.1</a>). </p> <p><a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a> reported 0/19 events in the erythromycin plus nasogastric tube lavage group and 2/22 events in the no intervention plus nasogastric tube lavage group. As the study authors had not specified the follow‐up duration for this outcome, we analysed the study as 'unknown follow‐up' (erythromycin 0%, no intervention 9.09%; RR 0.23, 95% CI 0.01 to 4.51; RD −0.09, 95% CI −0.24 to 0.05; 1 study, 41 participants; <a href="./references#CD013176-fig-0012" title="">Analysis 2.1</a>). </p> </section> <section id="CD013176-sec-0078"> <h5 class="title">Visualisation of gastric mucosa</h5> <p>Six RCTs addressed visualisation of gastric mucosa (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). All used continuous and dichotomous measures. </p> <p>For continuous measurement, <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>, <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>, and <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> used a scale of 0 to 3 points; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a> used a scale of 0 to 10 points; and <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> used a scale of 0 to 8 points. In all studies, a higher score indicated a clearer stomach. <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a> presented inconsistent continuous data that could not be used in the meta‐analysis of this outcome. <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> reported a median of 8 (IQR not reported) in the erythromycin plus nasogastric tube lavage group and 7 (IQR 5 to 8) in the no intervention plus nasogastric tube lavage group. <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> reported a median of 8 (IQR 7 to 8) in the erythromycin plus nasogastric tube lavage group and 8 (IQR 7 to 8) in the no intervention plus nasogastric tube lavage group. Given the skewed data (medians and IQRs), we were only able to meta‐analyse continuous data from <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>, <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>, and <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> (<a href="#CD013176-sec-0033">Measures of treatment effect</a>).  </p> <p> <ul id="CD013176-list-0020"> <li> <p>The evidence is very uncertain about the effect of erythromycin plus nasogastric tube lavage compared with no intervention/placebo plus nasogastric tube lavage on visualisation of gastric mucosa (SMD 0.48, 95% CI 0.10 to 0.85; I<sup>2</sup> = 25%; 3 studies, 170 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0013" title="">Analysis 2.2</a>). </p> </li> </ul> </p> <p>For dichotomous measurement, four RCTs used the judgement of the endoscopist, with different definitions of a clear stomach ("good endoscopic status" in <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>, "gastric mucosa entirely visualised" in <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a> and <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>, and "empty stomach" in <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). Meta‐analysis of these data showed no clear difference between erythromycin plus nasogastric tube lavage versus no intervention/placebo plus nasogastric tube lavage (erythromycin 79.76%, control 61.76%; RR 1.50, 95% CI 0.96 to 2.34; I<sup>2</sup> = 84%; 4 studies, 338 participants; <a href="./references#CD013176-fig-0014" title="">Analysis 2.3</a>). Three RCTs used cutoff points on ordinal scales to classify the stomach as empty or not empty (2 or more on a 3‐point scale in <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>, and 6 or more on an 8‐point scale in <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). Meta‐analysis of these data did not clearly favour erythromycin plus nasogastric tube lavage over no intervention/placebo plus nasogastric tube lavage (erythromycin 88.88%, no intervention 74.59%; RR 1.33, 95% CI 0.95 to 1.85; I<sup>2</sup> = 69%; 3 studies, 239 participants; <a href="./references#CD013176-fig-0014" title="">Analysis 2.3</a>). </p> </section> <section id="CD013176-sec-0079"> <h5 class="title">Non‐serious adverse events</h5> <p>Six RCTs addressed non‐serious adverse events (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>, <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>, and <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> reported no events in both groups. <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a> reported gastric contractions that reduced the quality of initial endoscopy (10/49 in the erythromycin plus nasogastric tube lavage group versus 7/50 in the placebo plus nasogastric tube lavage group). <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a> reported contractile activity that interfered with the quality of initial endoscopy or a haemostatic procedure (2/19 in the erythromycin plus nasogastric tube lavage group versus 3/22 in no intervention plus nasogastric tube lavage group). <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> reported severe pain after nasogastric tube placement (20/84 in the erythromycin plus nasogastric tube lavage group versus 24/85 in no intervention plus nasogastric tube lavage group). Two RTCs assessed non‐serious adverse events within one week and 30 days of initial endoscopy (<a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). Four RCTs did not report the follow‐up duration for this outcome (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>). </p> <p>The evidence is very uncertain about the effect of erythromycin plus nasogastric tube lavage compared with no intervention/placebo plus nasogastric tube lavage on non‐serious adverse events (erythromycin 15.92%, control 16.42%; RD 0.00, 95% CI −0.05 to 0.05; I<sup>2</sup> = 0%; 6 studies, 408 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0015" title="">Analysis 2.4</a>). </p> </section> <section id="CD013176-sec-0080"> <h5 class="title">Rebleeding</h5> <p>Five RCTs addressed rebleeding (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> addressed this outcome in the short term (within one week of initial endoscopy) and reported 19/84 events in the erythromycin plus nasogastric tube lavage group versus 17/85 events in no intervention plus nasogastric tube lavage group. The evidence is very uncertain about the effect of erythromycin plus nasogastric tube lavage compared with no intervention/placebo plus nasogastric tube lavage on rebleeding in the short term (erythromycin 22.61%, no intervention 20.0%; RR 1.13, 95% CI 0.63 to 2.02; 1 study, 169 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0016" title="">Analysis 2.5</a>). </p> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> addressed this outcome within 30 days of initial endoscopy. Meta‐analysis of these long‐term data showed no clear difference between the erythromycin and no intervention (erythromycin 22.4%, no intervention 19.0%; RR 1.07, 95% CI 0.61 to 1.87; I<sup>2</sup> = 0%; 198 participants; <a href="./references#CD013176-fig-0016" title="">Analysis 2.5</a>). </p> <p>Three RCTs addressed this outcome indirectly by reporting the proportion of participants who had a second‐look endoscopy (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>). However, no studies specified how many of these procedures were indicated for rebleeding. </p> </section> <section id="CD013176-sec-0081"> <h5 class="title">Blood transfusion</h5> <p>Six RCTs addressed blood transfusion (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). </p> <p>Four RCTs addressed this outcome in the short term (within one week of initial endoscopy; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). The unit of measurement was a standard unit of blood, as defined by the study authors (no studies reported the volume of each blood pack). <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a> and <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a> assessed blood transfusion within 48 hours of initial endoscopy, <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a> within 24 hours of initial endoscopy, and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> within one week of initial endoscopy. We were able to meta‐analyse data from three RCTs (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>). The evidence is very uncertain about the effect of erythromycin plus nasogastric tube lavage compared with no intervention/placebo plus nasogastric tube lavage on blood transfusion (MD −1.85 standard units of blood, 95% CI −4.34 to 0.64; I<sup>2</sup> = 93%; 3 studies, 180 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0017" title="">Analysis 2.6</a>). <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> reported a median of 2.5 (IQR 0 to 4.5) units of blood transfusion in the erythromycin plus nasogastric tube lavage group and 2 (IQR 0 to 4) units of blood transfusion in the no intervention plus nasogastric tube lavage group. </p> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> addressed blood transfusion within 30 days of initial endoscopy. We did not meta‐analyse these long‐term data as the RCTs provided only medians and IQRs, and we regarded these as skewed data (<a href="#CD013176-sec-0033">Measures of treatment effect</a>). <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> reported a median of 2 (IQR 0 to 3) units of blood transfusion in the erythromycin plus nasogastric tube lavage group versus 2 (IQR 0 to 3) units of blood transfusion in no intervention plus nasogastric tube lavage group. <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> reported a median of 3 (IQR 0 to 5) units of blood transfusion in the erythromycin plus nasogastric tube lavage group and 2 (IQR 0 to 4) units of blood transfusion in no intervention plus nasogastric tube lavage group. </p> <p><a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> did not specify the follow‐up duration for assessment of blood transfusion. The study reported a mean of 2.26 (SD not reported) units of blood transfusion in the erythromycin plus nasogastric tube lavage group and 2.86 (SD not reported) in the placebo plus nasogastric tube lavage group (95% CI not computed due to missing SDs; very low‐certainty evidence). </p> </section> <section id="CD013176-sec-0082"> <h5 class="title">Rescue invasive intervention</h5> <p>Two RCTs addressed rescue invasive intervention (<a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>). <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a> reported 1/19 events (emergency surgery) in the erythromycin plus nasogastric tube lavage group and 3/22 events (emergency surgery) in the no intervention plus nasogastric tube lavage group; however, the study authors did not report the follow‐up duration for this outcome. <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> reported 0/14 events in the erythromycin plus nasogastric tube lavage group and 1/15 events (angiographic embolisation) in the no intervention plus nasogastric tube lavage group, within one week and 30 days of initial endoscopy. Meta‐analysis of the data from these two RCTs showed no clear difference between erythromycin and no intervention (erythromycin 3.03%, control 10.81%; RR 0.38, 95% CI 0.06 to 2.24; I<sup>2</sup> = 0%; 70 participants; <a href="./references#CD013176-fig-0018" title="">Analysis 2.7</a>). </p> </section> </section> <section id="CD013176-sec-0083"> <h4 class="title">Comparison 3: Erythromycin versus nasogastric tube lavage</h4> <p>Four RCTs, totaling 287 participants, compared erythromycin with nasogastric tube lavage (<a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). </p> <section id="CD013176-sec-0084"> <h5 class="title">UGIH‐related mortality</h5> <p>The following two RCTs (44 participants) addressed UGIH‐related mortality and reported no events in either group (very low‐certainty evidence). </p> <p> <ul id="CD013176-list-0021"> <li> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>: 0/14 events in the erythromycin group versus 0/15 in the nasogastric tube lavage, within one week and 30 days of initial endoscopy </p> </li> <li> <p><a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>: 0/6 events in the erythromycin group versus 0/9 in the nasogastric tube lavage; however, the study authors did not report the follow‐up duration for this outcome. </p> </li> </ul> </p> <p>We did not perform subgroup or sensitivity analysis because meta‐analysis was not possible for this outcome. Only <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> defined the aetiology of the haemorrhage, and included only participants with non‐variceal UGIH. </p> </section> <section id="CD013176-sec-0085"> <h5 class="title">Serious adverse events</h5> <p>The following three RCTs (213 participants) addressed serious adverse events and reported no events in either group (very low‐certainty evidence). </p> <p> <ul id="CD013176-list-0022"> <li> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>: 0/14 in the erythromycin group versus 0/15 in the nasogastric tube lavage group, within one week and 30 days of initial endoscopy </p> </li> <li> <p><a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>: 0/84 in the erythromycin group versus 0/85 in the nasogastric tube lavage group, within one week and 30 days of initial endoscopy </p> </li> <li> <p><a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>: 0/6 in the erythromycin group versus 0/9 in the nasogastric tube lavage (follow‐up duration not defined) </p> </li> </ul> </p> <p>We did not perform sensitivity or subgroup analysis because meta‐analysis was not possible for this outcome. Only <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> specified the aetiology of haemorrhage, and included only participants with non‐variceal UGIH. </p> </section> <section id="CD013176-sec-0086"> <h5 class="title">All‐cause mortality</h5> <p>Three RCTs addressed all‐cause mortality (<a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> reported this outcome at one week and 30 days. <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> did not report the follow‐up duration for this outcome; however, the study authors reported no events in either group (0/6 in the erythromycin group versus 0/9 in the nasogastric tube lavage). The evidence is very uncertain about the effect of erythromycin compared with nasogastric tube lavage on all‐cause mortality in the short term (erythromycin 6.73%, nasogastric tube 4.58%; RD 0.02, 95% CI −0.05 to 0.08; I<sup>2</sup> = 0%; 3 studies, 213 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0019" title="">Analysis 3.1</a>). Meta‐analysis showed no clear difference between erythromycin and nasogastric tube lavage in the long term (erythromycin 9.18%, nasogastric tube 9.0%; RD 0.00, 95% CI −0.07 to 0.08; I<sup>2</sup> = 0%; 2 studies, 198 participants; <a href="./references#CD013176-fig-0019" title="">Analysis 3.1</a>). </p> </section> <section id="CD013176-sec-0087"> <h5 class="title">Visualisation of gastric mucosa</h5> <p>Four RCTs addressed visualisation of gastric mucosa (<a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). </p> <p>All four RCTs measured this outcome on a continuous scale, but we could not perform a meta‐analysis because <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a> did not define the measure of variability; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> provided only medians and IQRs, which we regarded as skewed data (<a href="#CD013176-sec-0033">Measures of treatment effect</a>); and <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> did not report the SD. The results of the individual RCTs are narratively described as follows. </p> <p> <ul id="CD013176-list-0023"> <li> <p><a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a> reported values of "8 ± 2.5" (not clear if SD or SE) in the erythromycin group and "7.8 ± 2.2" in the nasogastric tube lavage group for the outcome "subjective scale" (0 to 10 points, higher means cleaner); and values of "8.89 ± 2.5" in the erythromycin group and "8.64 ± 1.98" in the nasogastric tube lavage group for the outcome "objective scale" (0 to 10, higher means cleaner). </p> </li> <li> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> used a scale ranging from 0 to 8 points (higher means cleaner) and reported a median of 8 (IQR 6 to 8) in the erythromycin group and 7 (IQR 5 to 8) in the nasogastric tube lavage group. </p> </li> <li> <p><a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> used a scale ranging from 0 to 8 points (higher means cleaner) and reported a median of 8 (IQR not reported) in the erythromycin group and 8 (IQR 7 to 8) in the nasogastric tube lavage group. </p> </li> <li> <p><a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> used a scale ranging from 0 to 3 pointes (higher means cleaner) and reported a mean of 0.67 (SD not reported) in the erythromycin group and 1.89 (SD not reported) in the nasogastric tube lavage group. </p> </li> </ul> </p> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> reported visualisation of gastric mucosa with dichotomous measures. <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> reported the judgement of the endoscopist, who decided whether participants had an "empty stomach"; this was the case in 69/84 participants in the erythromycin group and 68/85 participants in the nasogastric tube lavage group (erythromycin 82.14%, nasogastric tube 80.0%; RR 1.03, 95% CI 0.89 to 1.19; 1 study, 169 participants; <a href="./references#CD013176-fig-0020" title="">Analysis 3.2</a>). <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> used a cutoff point on an ordinal scale (6 or more points on an 8‐point scale) to classify the stomach as empty or not empty. The evidence is very uncertain about the effect of erythromycin compared with nasogastric tube lavage on visualisation of the gastric mucosa (erythromycin 84.69%, nasogastric tube 79.0%; RR 1.19, 95% CI 0.79 to 1.79; I<sup>2</sup> = 70%; 2 studies, 198 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0020" title="">Analysis 3.2</a>). </p> </section> <section id="CD013176-sec-0088"> <h5 class="title">Non‐serious adverse events</h5> <p>Three RCTs addressed non‐serious adverse events (<a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> reported no events in either group (0/14 in the erythromycin group versus 0/15 in the nasogastric tube lavage group), within one week and 30 days from the initial endoscopy. <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> reported 0/84 events in the erythromycin group and 24/85 events (severe pain) in the nasogastric tube lavage group, within one week and 30 days of initial endoscopy. <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> reported no events in either group (0/6 in the erythromycin group versus 0/9 in the nasogastric tube lavage group) but did not specify the follow‐up duration for this outcome. The evidence is very uncertain about the effect of erythromycin compared with nasogastric tube lavage on non‐serious adverse events (erythromycin 0%, nasogastric tube 22.01%; RD −0.10, 95% CI −0.34 to 0.13; I<sup>2</sup> = 89%; 3 studies, 213 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0021" title="">Analysis 3.3</a>). </p> </section> <section id="CD013176-sec-0089"> <h5 class="title">Rebleeding</h5> <p>Two RCTs addressed rebleeding (<a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). </p> <p><a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed this outcome in the short term (within one week of initial endoscopy), and reported 13/84 events in the erythromycin group and 17/85 events in the nasogastric tube lavage group. The evidence is very uncertain about the effect of erythromycin compared with nasogastric tube lavage on rebleeding in the short term (erythromycin 15.47%, nasogastric tube 20.0%; RR 0.77, 95% CI 0.40 to 1.49; 1 study, 169 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0022" title="">Analysis 3.4</a>) </p> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed rebleeding within 30 days of initial endoscopy. Meta‐analysis of these long‐term data showed no clear difference between erythromycin and nasogastric tube lavage (erythromycin 20.40%, nasogastric tube 19.0%; RR 1.07, 95% CI 0.61 to 1.87; I<sup>2</sup> = 0%; 2 studies, 198 participants; <a href="./references#CD013176-fig-0022" title="">Analysis 3.4</a>). </p> </section> <section id="CD013176-sec-0090"> <h5 class="title">Blood transfusion</h5> <p>Four RCTs addressed blood transfusion (<a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). The unit of measurement was a standard unit of blood, as defined by the study authors (no studies reported the volume of each blood pack). </p> <p><a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> (169 participants) addressed this outcome in the short term (within one week of initial endoscopy) and reported a median of 2 (IQR 0 to 4) units of blood transfusion in the erythromycin group and 2 (IQR 0 to 4) units of blood transfusion in the nasogastric tube lavage group (very low‐certainty evidence). </p> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed blood transfusion in the long term (within 30 days of initial endoscopy). We did not meta‐analyse their results because both studies provided only medians and IQRs, which we regarded as skewed data (<a href="#CD013176-sec-0033">Measures of treatment effect</a>). <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> reported a median of 1 (IQR 0 to 2) unit of blood transfusion in the erythromycin group and 2 (IQR 0 to 3) units of blood transfusion in the nasogastric tube lavage group. <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> reported a median of 2 (IQR 0 to 4) units of blood transfusion in the erythromycin group and 2 (IQR 0 to 4) units of blood transfusion in the nasogastric tube lavage group. </p> <p><a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a> and <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> assessed blood transfusion but provided no data and no definition of the follow‐up duration. Both RCTs stated that there was no difference in transfusion requirements between the groups. </p> </section> <section id="CD013176-sec-0091"> <h5 class="title">Rescue invasive intervention</h5> <p>Two RCTs addressed rescue invasive intervention (<a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> reported 0/14 events in the erythromycin group and 1/15 events (angiographic embolisation) in the nasogastric tube lavage group within one week and 30 days of initial endoscopy. <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> reported 0/6 events in the erythromycin group and 2/9 events (surgery) in the nasogastric tube lavage group, but did not report the follow‐up duration for this outcome. Meta‐analysis of these data showed no clear difference between erythromycin and nasogastric tube lavage in the short term (erythromycin 0%, nasogastric tube 12.5%; RR 0.32, 95% CI 0.04 to 2.62; I<sup>2</sup> = 0%; 2 studies, 44 participants; <a href="./references#CD013176-fig-0023" title="">Analysis 3.5</a>) or in the long term (erythromycin 0%, nasogastric tube 6.66%; RR 0.36, 95% CI 0.02 to 8.07; 1 study, 29 participants; <a href="./references#CD013176-fig-0023" title="">Analysis 3.5</a>). </p> </section> </section> <section id="CD013176-sec-0092"> <h4 class="title">Comparison 4: Erythromycin plus nasogastric tube lavage versus metoclopramide plus nasogastric tube lavage </h4> <p>One RCT (30 participants) compared erythromycin plus nasogastric tube lavage with metoclopramide plus nasogastric tube lavage (<a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>). </p> <section id="CD013176-sec-0093"> <h5 class="title">UGIH‐related mortality</h5> <p><a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> did not measure UGIH‐related mortality. </p> </section> <section id="CD013176-sec-0094"> <h5 class="title">Serious adverse events</h5> <p><a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> reported 0/15 serious adverse events in both groups (very low‐certainty evidence) and did not specify the follow‐up duration for this outcome. </p> <p>We did not perform sensitivity or subgroup analysis because this comparison included only one RCT. </p> </section> <section id="CD013176-sec-0095"> <h5 class="title">All‐cause mortality</h5> <p><a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> did not measure all‐cause mortality. </p> </section> <section id="CD013176-sec-0096"> <h5 class="title">Visualisation of gastric mucosa</h5> <p><a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> used a scale of 0 to 3 (higher means cleaner) to measure "quality of visualisation", and reported a mean of 2.53 (SD not reported) in the erythromycin plus nasogastric tube lavage group and 2.00 (SD not reported) in the metoclopramide plus nasogastric tube lavage group. <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> also reported the outcome "gastric mucosa entirely visualised" in 13/15 participants in the erythromycin plus nasogastric tube lavage group and 10/15 participants in the metoclopramide plus nasogastric tube lavage group. The evidence is very uncertain about the effect of erythromycin plus nasogastric tube lavage compared with metoclopramide plus nasogastric tube lavage on visualisation of gastric mucosa (erythromycin 86.66%, metoclopramide 66.66%; RR 1.30, 95% CI 0.86 to 1.96; 1 study, 30 participants; very low‐certainty evidence; <a href="./references#CD013176-fig-0024" title="">Analysis 4.1</a>). </p> </section> <section id="CD013176-sec-0097"> <h5 class="title">Non‐serious adverse events</h5> <p><a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> reported 0/15 non‐serious adverse events in both groups (very low‐certainty evidence) and did not specify the follow‐up duration for this outcome. </p> </section> <section id="CD013176-sec-0098"> <h5 class="title">Rebleeding</h5> <p><a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> did not measure rebleeding. </p> </section> <section id="CD013176-sec-0099"> <h5 class="title">Blood transfusion</h5> <p><a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> reported a mean of 2.26 (SD not reported) units of blood transfusion in the erythromycin plus nasogastric tube lavage group and 3.66 (SD not reported) in the metoclopramide plus nasogastric tube lavage group (95% CI not computed due to missing SDs; very low‐certainty evidence). The study authors did not report the follow‐up duration for this outcome. </p> </section> <section id="CD013176-sec-0100"> <h5 class="title">Rescue invasive intervention</h5> <p><a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> did not measure rescue invasive intervention. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD013176-sec-0101" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD013176-sec-0101"></div> <section id="CD013176-sec-0102"> <h3 class="title" id="CD013176-sec-0102">Summary of main results</h3> <p>This review included 11 RCTs with a parallel‐group design, published between 1996 and 2020, with a total of 878 participants. In all studies, a group of participants were randomised to erythromycin before initial upper endoscopy for UGIH. We identified four comparisons for this review. </p> <section id="CD013176-sec-0103"> <h4 class="title">Erythromycin versus no intervention/placebo</h4> <p>Three RCTs compared erythromycin with placebo (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>). There was low‐certainty evidence, based on continuous data, that erythromycin may improve visualisation of the gastric mucosa; however, the clinical relevance of this finding is unknown. One RCT showed that erythromycin may result in a slight reduction in the number of red blood cells packs transfused, with low‐certainty evidence. For all other outcomes, the evidence is very uncertain about the effects of erythromycin in the short or long term. </p> </section> <section id="CD013176-sec-0104"> <h4 class="title">Erythromycin plus nasogastric tube lavage versus no intervention/placebo plus nasogastric tube lavage </h4> <p>Six RCTs compared erythromycin plus nasogastric tube lavage with no intervention/placebo plus nasogastric tube lavage (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). The evidence is very uncertain about the effects of erythromycin plus nasogastric tube lavage on all outcomes in the short or long term. </p> </section> <section id="CD013176-sec-0105"> <h4 class="title">Erythromycin versus nasogastric tube lavage</h4> <p>Four RCTs compared erythromycin with nasogastric tube lavage (<a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). The evidence is very uncertain about the effects of erythromycin on all outcomes in the short or long term. </p> </section> <section id="CD013176-sec-0106"> <h4 class="title">Erythromycin plus nasogastric tube lavage versus metoclopramide plus nasogastric tube lavage </h4> <p>One RCT compared erythromycin plus nasogastric tube lavage with metoclopramide plus nasogastric tube lavage (<a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>). The evidence is very uncertain about the effects of erythromycin plus nasogastric tube lavage on all reported outcomes (serious adverse events, visualisation of gastric mucosa, non‐serious adverse events, and blood transfusion). </p> </section> </section> <section id="CD013176-sec-0107"> <h3 class="title" id="CD013176-sec-0107">Overall completeness and applicability of evidence</h3> <p>This review aimed to assess whether erythromycin administered to people with UGIH was effective and safe for clearing the stomach before initial endoscopy. There was scarce evidence addressing this issue, and only 11 studies met our inclusion criteria. </p> <section id="CD013176-sec-0108"> <h4 class="title">Participants</h4> <p>Only two RCTs differentiated non‐variceal from variceal aetiology, and each included only one aetiology in the sample (<a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>). The remaining nine RCTs did not distinguish between participants with non‐variceal or variceal haemorrhage, only between those who did or did not have cirrhosis. However, many participants with cirrhosis may have bleeding of a non‐variceal aetiology, such as a peptic ulcer. No studies correlated the specific source of bleeding (e.g. peptic ulcer, oesophageal varices, stomach varices, or Mallory‐Weiss) with any outcome. </p> </section> <section id="CD013176-sec-0109"> <h4 class="title">Interventions</h4> <p>We identified two different erythromycin interventions: erythromycin as monotherapy (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>) and erythromycin plus nasogastric tube lavage (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). As nasogastric tube lavage is no longer recommended, our review findings may have limited applicability in clinical practice. In addition, the included RCTs administered different doses of erythromycin, ranging from 125 mg to 500 mg (parenteral and oral); this may have introduced heterogeneity to the magnitude of the effect and adverse events. </p> <p>We identified three comparators, all of which were highly valid for determining the real effectiveness of erythromycin in clinical practice: placebo/no intervention, nasogastric tube lavage, and another prokinetic drug (metoclopramide). However, the small samples with few events reduced the certainty of the evidence according to GRADE criteria, limiting our conclusions about the effectiveness and safety of erythromycin versus these comparators. </p> </section> <section id="CD013176-sec-0110"> <h4 class="title">Outcomes</h4> <p>Only five RCTs reported both of the primary outcomes planned in this review (UGIH‐related mortality and serious adverse events; <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). There were no UGIH‐related deaths and only two serious adverse events (aspiration pneumonia), which limits the certainty of the evidence in GRADE and our conclusions about the effectiveness and safety of the intervention. </p> <p>We found heterogeneity between studies in the method of assessing gastric mucosa visibility. Some studies used a discrete numerical scale, some determined a cutoff point on a scale to dichotomise the outcome, and some used the opinion of the endoscopist (e.g. clean stomach, yes or no). We were unable to determine the clinical relevance of improvement or worsening by one or more points on the gastric mucosa visibility scales when we meta‐analysed the results. The only way to overcome this limitation would be to standardise gastric mucosa visualisation scales and define the real clinical benefit or harm of variation by one or more points. </p> <p>Only two RCTS directly assessed rebleeding after endoscopy (<a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). The remaining studies evaluated rebleeding rate indirectly through the proportion of participants who had a second‐look endoscopy. However, rebleeding is not the only motive for second‐look endoscopies, as participants may present haemodynamic changes for other reasons. Therefore, we chose not to combine second‐look results with rebleed results. </p> <p>Nine RCTs assessed the need for blood transfusion (<a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>); however, only <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> provided information (via email) on the type of infused blood component (red blood cells) and the volume of each pack (250 mL to 275 mL). For an accurate comparison, study authors should report exactly the type of transfused blood product (red blood cells, plasma, or platelets) and the precise volume administered to each participant during hospitalisation. Regarding follow‐up time, two studies reported units transfused at seven days (short term) and at 30 days (long term; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>). Five studies limited follow‐up of blood transfusion to 24 hours or 48 hours after initial endoscopy (<a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>). This seems insufficient, as many participants may have required a blood transfusion more than 48 hours after the initial endoscopy. </p> <p>Five RCTs reported the outcome of rescue invasive intervention (<a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a>). However, the small number of events (12 in total) limited the certainty of the evidence in GRADE and our conclusions about the effectiveness and safety of the intervention. </p> <p>Regarding subgroup analysis, no studies stratified results by participant age or comorbidities.</p> <p>Clinical guidelines published in 2021 on the use of erythromycin in non‐variceal UGIH recommend "an infusion of erythromycin before endoscopy in patients with UGIB (conditional recommendation, very‐low‐quality evidence)" (<a href="./references#CD013176-bbs2-0061" title="LaineL , BarkunAN , SaltzmanJR , MartelM , LeontiadisGI . ACG clinical guideline: upper gastrointestinal and ulcer bleeding. American Journal of Gastroenterology2021;116(5):899-917.">Laine 2021</a>). The same guidelines state that "although evidence was lacking for benefit of erythromycin in reducing further bleeding and mortality, erythromycin provided meaningful reductions in repeat endoscopies and length of hospitalizations: e.g., the upper bound of the 95% CI suggested at least a 1‐day decrease in hospitalization. The economic benefit of reduced procedures and hospital stay, as well as the presumed desire of patients to avoid additional procedures and hospital days, relatively low cost, and ease of administration, led the panel to a conditional recommendation for use of pre‐endoscopic erythromycin". Similarly, a guideline on variceal UGIH published in 2022 suggests that "in the absence of contraindications (QT prolongation), pre‐endoscopy infusion of erythromycin (250 mg IV 30‐120 minutes before endoscopy) should be considered (B.1)" (<a href="./references#CD013176-bbs2-0040" title="deFranchisR , BoschJ , Garcia-TsaoG , ReibergerT , RipollC , Baveno VII Faculty. Baveno VII – Renewing consensus in portal hypertension. Journal of Hepatology2022;76(4):959-74.">de Franchis 2022</a>). We did not find sufficient indirect evidence to reach any conclusion on the need for further endoscopy (through the rebleeding outcome), and we did not assess length of hospital stay or costs. We found low‐certainty evidence indicating improved stomach visualisation and a slight reduction in the need for transfusion when comparing erythromycin to placebo. As visualisation of the gastric mucosa is a surrogate secondary outcome, and the possible reduction in blood transfusion is slight, we could not reach any firm conclusions about the benefits and harms of erythromycin. </p> </section> <section id="CD013176-sec-0111"> <h4 class="title">Summary</h4> <p>The studies included in this review were few and small, with few reported events. In addition, data were heterogeneous in terms of populations (mixture of non‐variceal and variceal aetiology), comparisons (different routes and doses of erythromycin and different comparators), and outcomes (inaccurate measurements and non‐standard tools, scales without precise clinical correspondence). The literature has not investigated the most relevant types of participants, interventions and outcomes. </p> </section> </section> <section id="CD013176-sec-0112"> <h3 class="title" id="CD013176-sec-0112">Quality of the evidence</h3> <p>The evidence on all outcomes assessed in this review was of low or very low certainty.</p> <p>In the comparison of erythromycin versus placebo, the global certainty of the evidence was low and very low (<a href="./full#CD013176-tbl-0001">summary of findings Table 1</a>). The main reasons for downgrading the evidence were risk of bias (incomplete outcome data, baseline imbalance, and selective reporting) and imprecision (small sample size, low number of events, and wide 95% CI). </p> <p>In the comparison of erythromycin plus nasogastric tube lavage versus no intervention/placebo plus nasogastric tube lavage, the global certainty of the evidence was very low for all outcomes (<a href="./full#CD013176-tbl-0002">summary of findings Table 2</a>). The reasons for downgrading the evidence were risk of bias (blinding of participants and personnel, blinding of outcome assessment, selective reporting, and baseline imbalance), inconsistency (high heterogeneity), and imprecision (small sample size, low number of events, and wide 95% CI). </p> <p>In the comparison of erythromycin versus nasogastric tube lavage, the global certainty of the evidence was very low for all outcomes (<a href="./full#CD013176-tbl-0003">summary of findings Table 3</a>). The reasons for downgrading the evidence were risk of bias (blinding of participants and personnel, blinding of outcome assessment, and selective reporting), inconsistency (high heterogeneity), and imprecision (small sample size, low number of events, and wide 95% CI). </p> <p>In the comparison of erythromycin plus nasogastric tube lavage versus metoclopramide plus nasogastric tube lavage, the certainty of the evidence was very low for all outcomes (<a href="./full#CD013176-tbl-0004">summary of findings Table 4</a>). The reasons for downgrading the evidence were risk of bias (insufficient information for the judgement of all domains) and imprecision (small sample size, low number of events, wide 95% CI, and missing SDs). </p> </section> <section id="CD013176-sec-0113"> <h3 class="title" id="CD013176-sec-0113">Potential biases in the review process</h3> <p>We conducted this review with the highest rigour to minimise the risk of bias. We performed a comprehensive and sensitive literature search, without limitations on year of publication, language, or publication status. Two review authors independently assessed each study for inclusion, extracted data, and assessed study quality. We intended to include all eligible studies; however, one potentially eligible study was in Polish (<a href="./references#CD013176-bbs2-0025" title="RudzkiS , CzekalowskiS , MichalakK , KuszW , FularzA . Erythromycin improves quality of endoscopy for acute upper gastrointestinal bleeding [Erytromycyna jako czynnik poprawiajacy jakość badania endoskopowego w ostrych krwawieniach z górnego odcinka przewodu pokarmowego]. Wiadomości Lekarskie2006;59:490-1. ">Rudzki 2006</a>) and, even with the rigorous translation, we may have missed some relevant content. It was unclear whether the study was an RCT, and as we received no response from the study authors after several attempts to contact them, we decided to exclude the study. </p> <p>Several attempts to obtain missing data were unsuccessful. We tried to contact the authors of all included studies by email and telephone. However, only the authors of <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> replied. Therefore, there were missing data related to risk of bias, interventions, comparators, outcomes, and follow‐up analysis, and we could not perform the planned subgroup analyses. </p> <p>Regarding the synthesis of data, one RCT did not report SDs, so we could not compute CIs (<a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>). Two RCTs reported central tendency and dispersion data as medians and IQRs, and we chose not meta‐analyse these data as it would require conversion to mean and CI (<a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; see <a href="#CD013176-sec-0134">Differences between protocol and review</a>). </p> </section> <section id="CD013176-sec-0114"> <h3 class="title" id="CD013176-sec-0114">Agreements and disagreements with other studies or reviews</h3> <p><a href="#CD013176-tbl-0005">Table 1</a> summarises the main agreements and disagreements with previous published reviews. </p> <div class="table" id="CD013176-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Agreements and disagreements among reviews</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Review</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Included RCTs</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Main outcomes</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0030" title="BaiY , GuoJF , LiZS . Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding. Alimentary Pharmacology and Therapeutics2011;34:166-71.">Bai 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Erythromycin versus control in UGIH (2 trials used nasogastric tube with gastric lavage before erythromycin infusion, and 2 trials did not allow nasogastric tube with gastric lavage). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013176-list-0024"> <li> <p>UGIH‐related mortality: not assessed</p> </li> <li> <p>SAEs: not assessed</p> </li> <li> <p>All‐cause mortality: lower in erythromycin group (RR 0.51, 95% CI 0.17 to 1.52, P = 0.23), although 95% CI crossed line of no effect </p> </li> <li> <p>Visualisation of gastric mucosa: improved in erythromycin group (RR 1.90, 95% CI 1.53 to 2.37, P &lt; 0.001) </p> </li> <li> <p>Blood transfusion: reduced in erythromycin group (MD −0.51, 95% CI −0.95 to −0.07, P = 0.02) </p> </li> <li> <p>Rescue invasive intervention: not assessed</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0031" title="BarkunAN , BardouM , MartelM , GralnekIM , SungJJ . Prokinetics in acute upper GI bleeding: a meta-analysis. Gastrointestinal Endoscopy2010;72(6):1138-45.">Barkun 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Erythromycin and metoclopramide versus placebo or no treatment in UGIH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs that used erythromycin as an intervention: <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013176-list-0025"> <li> <p>UGIH‐related mortality: not assessed</p> </li> <li> <p>SAEs: not assessed</p> </li> <li> <p>All‐cause mortality: not assessed</p> </li> <li> <p>Visualisation of gastric mucosa: endoscopic visualisation not analysed because disparate definitions across studies prevented meaningful clinical inferences </p> </li> <li> <p>Blood transfusion: not significantly reduced in erythromycin group versus placebo group (WMD −0.98, 95% CI −2.81 to 0.85) and no treatment (WMD −0.48, 95% CI −0.97 to 0.01) </p> </li> <li> <p>Rescue invasive intervention: need for surgery not significantly reduced in erythromycin group (OR 1.11, 95% CI 0.27 to 4.67) </p> </li> </ul> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0048" title="GuixiangS , JunW , FangT , YaoL , YoupingL , AiqingW . The effect of acute variceal bleeding interventions on reducing the requirement of blood transfusions in cirrhotic patients: a systematic review. International Journal of Clinical and Experimental Medicine2016;9(3):6166-77.">Guixiang 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Any intervention versus any control for management of variceal bleeding in people with liver cirrhosis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs that used erythromycin as an intervention: <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013176-list-0026"> <li> <p>UGIH‐related mortality: not assessed</p> </li> <li> <p>SAEs: not assessed</p> </li> <li> <p>All‐cause mortality: not assessed</p> </li> <li> <p>Visualisation of gastric mucosa: not assessed</p> </li> <li> <p>Blood transfusion: data from <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> only (no difference between groups) </p> </li> <li> <p>Rescue invasive intervention: not assessed</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0074" title="RahmanR , NguyenDL , SohailU , AlmashhrawiAA , AshrafI , PuliSR , et al. Pre-endoscopic erythromycin administration in upper gastrointestinal bleeding: an updated meta-analysis and systematic review. Annals of Gastroenterology2016;29:312-7.">Rahman 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Erythromycin before endoscopy versus no erythromycin or placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0025" title="RudzkiS , CzekalowskiS , MichalakK , KuszW , FularzA . Erythromycin improves quality of endoscopy for acute upper gastrointestinal bleeding [Erytromycyna jako czynnik poprawiajacy jakość badania endoskopowego w ostrych krwawieniach z górnego odcinka przewodu pokarmowego]. Wiadomości Lekarskie2006;59:490-1. ">Rudzki 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013176-list-0027"> <li> <p>UGIH‐related mortality: not assessed</p> </li> <li> <p>SAEs: not assessed</p> </li> <li> <p>All‐cause mortality: not assessed</p> </li> <li> <p>Visualisation of gastric mucosa: higher frequency of adequate gastric mucosa visualisation in erythromycin group (OR 4.14, 95% CI 2.01 to 8.53, P &lt; 0.01) </p> </li> <li> <p>Blood transfusion: no clear difference between erythromycin and no erythromycin in amount of blood transfusions required (MD −1.06, 95% CI − 2.24 to 0.13, P = 0.08). After exclusion of <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>, amount of blood transfusions was lower in erythromycin group (MD −0.41, 95% CI −0.82 to −0.01, P = 0.04). </p> </li> <li> <p>Rescue invasive intervention: no difference in need for emergency surgery (OR 1.11, 95% CI 0.27 to 4.67, P = 0.88) </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0082" title="SzaryNM , GuptaR , ChoudharyA , MattesonML , ArifM , HammadTH , et al. Erythromycin prior to endoscopy in acute upper gastrointestinal bleeding: a meta-analysis. Scandinavian Journal of Gastroenterology2011;46:920-4.">Szary 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Erythromycin infusion versus no erythromycin in UGIH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0025" title="RudzkiS , CzekalowskiS , MichalakK , KuszW , FularzA . Erythromycin improves quality of endoscopy for acute upper gastrointestinal bleeding [Erytromycyna jako czynnik poprawiajacy jakość badania endoskopowego w ostrych krwawieniach z górnego odcinka przewodu pokarmowego]. Wiadomości Lekarskie2006;59:490-1. ">Rudzki 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013176-list-0028"> <li> <p>UGIH‐related mortality: not assessed</p> </li> <li> <p>SAEs: not assessed</p> </li> <li> <p>All‐cause mortality: not assessed</p> </li> <li> <p>Visualisation of gastric mucosa: improved in erythromycin group (OR 4.89, 95% CI 2.85 to 8.38, P &lt; 0.01) </p> </li> <li> <p>Blood transfusion: fewer units of blood transfused in erythromycin group (WMD −0.48, 95% CI −0.97 to 0.01, P = 0.05), though 95% CI included no effect </p> </li> <li> <p>Rescue invasive intervention: not assessed</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0084" title="TheivanayagamS , LimRG , CobellWJ , GowdaJT , MattesonML , ChoudharyA , et al. Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. Saudi Journal of Gastroenterology2013;19(5):205-10.">Theivanayagam 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Erythromycin versus no erythromycin in UGIH (RCTs that performed nasogastric lavage on only 1 group were excluded) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0025" title="RudzkiS , CzekalowskiS , MichalakK , KuszW , FularzA . Erythromycin improves quality of endoscopy for acute upper gastrointestinal bleeding [Erytromycyna jako czynnik poprawiajacy jakość badania endoskopowego w ostrych krwawieniach z górnego odcinka przewodu pokarmowego]. Wiadomości Lekarskie2006;59:490-1. ">Rudzki 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013176-list-0029"> <li> <p>UGIH‐related mortality: not assessed</p> </li> <li> <p>SAEs: not assessed</p> </li> <li> <p>All‐cause mortality: not assessed</p> </li> <li> <p>Visualisation of gastric mucosa: improved in erythromycin group (OR 3.43, 95% CI 1.81 to 6.50, P &lt; 0.01) </p> </li> <li> <p>Blood transfusion: need for blood transfusion reduced in erythromycin group (WMD −0.41, 95% CI −0.82 to −0.01, P = 0.04) </p> </li> <li> <p>Rescue invasive intervention: not assessed</p> </li> </ul> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adao 2022 (current review)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013176-list-0030"> <li> <p>Erythromycin versus placebo</p> </li> <li> <p>Erythromycin plus nasogastric tube lavage versus no intervention/placebo plus nasogastric tube lavage </p> </li> <li> <p>Erythromycin versus nasogastric tube lavage</p> </li> <li> <p>Erythromycin plus nasogastric tube lavage versus metoclopramide plus nasogastric tube lavage </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For the comparison erythromycin versus placebo:</p> <p> <ul id="CD013176-list-0031"> <li> <p>UGIH‐related mortality: no UGIH‐related deaths in either group</p> </li> <li> <p>SAEs: evidence is very uncertain (RD −0.01, 95% CI −0.04 to 0.02).</p> </li> <li> <p>All‐cause mortality: evidence is very uncertain (RD −0.00, 95% CI −0.03 to 0.03).</p> </li> <li> <p>Visualisation of gastric mucosa: erythromycin may increase visualisation of gastric mucosa (MD 3.63, 95% CI 2.2 to 5.05). </p> </li> <li> <p>Blood transfusion: erythromycin may result in a slight reduction in blood transfusion (MD −0.44, 95% CI −0.86 to −0.01). </p> </li> <li> <p>Rescue invasive intervention: evidence is very uncertain (RD 0.01, 95% CI −0.03 to 0.06). </p> </li> </ul> </p> <p> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; MD: mean difference; OR: odds ratio; RD: risk difference; RR: risk ratio; SAE: serious adverse event; UGIH: upper gastrointestinal haemorrhage; WMD: weighted mean difference. </p> </div> </div> <p>We identified six reviews that attempted to answer similar questions to those addressed in this systematic review (<a href="./references#CD013176-bbs2-0030" title="BaiY , GuoJF , LiZS . Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding. Alimentary Pharmacology and Therapeutics2011;34:166-71.">Bai 2011</a>; <a href="./references#CD013176-bbs2-0031" title="BarkunAN , BardouM , MartelM , GralnekIM , SungJJ . Prokinetics in acute upper GI bleeding: a meta-analysis. Gastrointestinal Endoscopy2010;72(6):1138-45.">Barkun 2010</a>; <a href="./references#CD013176-bbs2-0048" title="GuixiangS , JunW , FangT , YaoL , YoupingL , AiqingW . The effect of acute variceal bleeding interventions on reducing the requirement of blood transfusions in cirrhotic patients: a systematic review. International Journal of Clinical and Experimental Medicine2016;9(3):6166-77.">Guixiang 2016</a>; <a href="./references#CD013176-bbs2-0074" title="RahmanR , NguyenDL , SohailU , AlmashhrawiAA , AshrafI , PuliSR , et al. Pre-endoscopic erythromycin administration in upper gastrointestinal bleeding: an updated meta-analysis and systematic review. Annals of Gastroenterology2016;29:312-7.">Rahman 2016</a>; <a href="./references#CD013176-bbs2-0082" title="SzaryNM , GuptaR , ChoudharyA , MattesonML , ArifM , HammadTH , et al. Erythromycin prior to endoscopy in acute upper gastrointestinal bleeding: a meta-analysis. Scandinavian Journal of Gastroenterology2011;46:920-4.">Szary 2011</a>; <a href="./references#CD013176-bbs2-0084" title="TheivanayagamS , LimRG , CobellWJ , GowdaJT , MattesonML , ChoudharyA , et al. Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. Saudi Journal of Gastroenterology2013;19(5):205-10.">Theivanayagam 2013</a>). The most recent review is from 2016 and the oldest is from 2010. </p> <p>Four reviews did not perform a sensitive literature search, restricting the search strategy to some free texts terms (<a href="./references#CD013176-bbs2-0030" title="BaiY , GuoJF , LiZS . Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding. Alimentary Pharmacology and Therapeutics2011;34:166-71.">Bai 2011</a>; <a href="./references#CD013176-bbs2-0048" title="GuixiangS , JunW , FangT , YaoL , YoupingL , AiqingW . The effect of acute variceal bleeding interventions on reducing the requirement of blood transfusions in cirrhotic patients: a systematic review. International Journal of Clinical and Experimental Medicine2016;9(3):6166-77.">Guixiang 2016</a>; <a href="./references#CD013176-bbs2-0082" title="SzaryNM , GuptaR , ChoudharyA , MattesonML , ArifM , HammadTH , et al. Erythromycin prior to endoscopy in acute upper gastrointestinal bleeding: a meta-analysis. Scandinavian Journal of Gastroenterology2011;46:920-4.">Szary 2011</a>; <a href="./references#CD013176-bbs2-0084" title="TheivanayagamS , LimRG , CobellWJ , GowdaJT , MattesonML , ChoudharyA , et al. Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. Saudi Journal of Gastroenterology2013;19(5):205-10.">Theivanayagam 2013</a>). Three reviews performed the search in only a few databases (e.g. CINAHL not included; <a href="./references#CD013176-bbs2-0030" title="BaiY , GuoJF , LiZS . Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding. Alimentary Pharmacology and Therapeutics2011;34:166-71.">Bai 2011</a>; <a href="./references#CD013176-bbs2-0031" title="BarkunAN , BardouM , MartelM , GralnekIM , SungJJ . Prokinetics in acute upper GI bleeding: a meta-analysis. Gastrointestinal Endoscopy2010;72(6):1138-45.">Barkun 2010</a>; <a href="./references#CD013176-bbs2-0048" title="GuixiangS , JunW , FangT , YaoL , YoupingL , AiqingW . The effect of acute variceal bleeding interventions on reducing the requirement of blood transfusions in cirrhotic patients: a systematic review. International Journal of Clinical and Experimental Medicine2016;9(3):6166-77.">Guixiang 2016</a>). Four reviews restricted the search by language of publication (<a href="./references#CD013176-bbs2-0031" title="BarkunAN , BardouM , MartelM , GralnekIM , SungJJ . Prokinetics in acute upper GI bleeding: a meta-analysis. Gastrointestinal Endoscopy2010;72(6):1138-45.">Barkun 2010</a> included only English and French RCTs, <a href="./references#CD013176-bbs2-0048" title="GuixiangS , JunW , FangT , YaoL , YoupingL , AiqingW . The effect of acute variceal bleeding interventions on reducing the requirement of blood transfusions in cirrhotic patients: a systematic review. International Journal of Clinical and Experimental Medicine2016;9(3):6166-77.">Guixiang 2016</a> included only English RCTs, and <a href="./references#CD013176-bbs2-0074" title="RahmanR , NguyenDL , SohailU , AlmashhrawiAA , AshrafI , PuliSR , et al. Pre-endoscopic erythromycin administration in upper gastrointestinal bleeding: an updated meta-analysis and systematic review. Annals of Gastroenterology2016;29:312-7.">Rahman 2016</a> and <a href="./references#CD013176-bbs2-0082" title="SzaryNM , GuptaR , ChoudharyA , MattesonML , ArifM , HammadTH , et al. Erythromycin prior to endoscopy in acute upper gastrointestinal bleeding: a meta-analysis. Scandinavian Journal of Gastroenterology2011;46:920-4.">Szary 2011</a> included only English and Polish RCTs). <a href="./references#CD013176-bbs2-0030" title="BaiY , GuoJF , LiZS . Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding. Alimentary Pharmacology and Therapeutics2011;34:166-71.">Bai 2011</a> limited the search results to fully reported RCTs with detailed information. </p> <p><a href="./references#CD013176-bbs2-0031" title="BarkunAN , BardouM , MartelM , GralnekIM , SungJJ . Prokinetics in acute upper GI bleeding: a meta-analysis. Gastrointestinal Endoscopy2010;72(6):1138-45.">Barkun 2010</a> and <a href="./references#CD013176-bbs2-0074" title="RahmanR , NguyenDL , SohailU , AlmashhrawiAA , AshrafI , PuliSR , et al. Pre-endoscopic erythromycin administration in upper gastrointestinal bleeding: an updated meta-analysis and systematic review. Annals of Gastroenterology2016;29:312-7.">Rahman 2016</a> included only RCTs that compared erythromycin versus placebo or no intervention. <a href="./references#CD013176-bbs2-0084" title="TheivanayagamS , LimRG , CobellWJ , GowdaJT , MattesonML , ChoudharyA , et al. Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. Saudi Journal of Gastroenterology2013;19(5):205-10.">Theivanayagam 2013</a> did not include RCTs that compared erythromycin versus nasogastric tube lavage (only studies with nasogastric tube lavage in both treatment arms). As a result, these reviews missed some relevant RCTs. </p> <p>All reviews included a smaller number of RCTs with an erythromycin group than our systematic review (one in <a href="./references#CD013176-bbs2-0048" title="GuixiangS , JunW , FangT , YaoL , YoupingL , AiqingW . The effect of acute variceal bleeding interventions on reducing the requirement of blood transfusions in cirrhotic patients: a systematic review. International Journal of Clinical and Experimental Medicine2016;9(3):6166-77.">Guixiang 2016</a>; four <a href="./references#CD013176-bbs2-0030" title="BaiY , GuoJF , LiZS . Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding. Alimentary Pharmacology and Therapeutics2011;34:166-71.">Bai 2011</a>, <a href="./references#CD013176-bbs2-0031" title="BarkunAN , BardouM , MartelM , GralnekIM , SungJJ . Prokinetics in acute upper GI bleeding: a meta-analysis. Gastrointestinal Endoscopy2010;72(6):1138-45.">Barkun 2010</a>, and <a href="./references#CD013176-bbs2-0082" title="SzaryNM , GuptaR , ChoudharyA , MattesonML , ArifM , HammadTH , et al. Erythromycin prior to endoscopy in acute upper gastrointestinal bleeding: a meta-analysis. Scandinavian Journal of Gastroenterology2011;46:920-4.">Szary 2011</a>; seven in <a href="./references#CD013176-bbs2-0084" title="TheivanayagamS , LimRG , CobellWJ , GowdaJT , MattesonML , ChoudharyA , et al. Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. Saudi Journal of Gastroenterology2013;19(5):205-10.">Theivanayagam 2013</a>; and eight in <a href="./references#CD013176-bbs2-0074" title="RahmanR , NguyenDL , SohailU , AlmashhrawiAA , AshrafI , PuliSR , et al. Pre-endoscopic erythromycin administration in upper gastrointestinal bleeding: an updated meta-analysis and systematic review. Annals of Gastroenterology2016;29:312-7.">Rahman 2016</a>). <a href="./references#CD013176-bbs2-0074" title="RahmanR , NguyenDL , SohailU , AlmashhrawiAA , AshrafI , PuliSR , et al. Pre-endoscopic erythromycin administration in upper gastrointestinal bleeding: an updated meta-analysis and systematic review. Annals of Gastroenterology2016;29:312-7.">Rahman 2016</a>, <a href="./references#CD013176-bbs2-0082" title="SzaryNM , GuptaR , ChoudharyA , MattesonML , ArifM , HammadTH , et al. Erythromycin prior to endoscopy in acute upper gastrointestinal bleeding: a meta-analysis. Scandinavian Journal of Gastroenterology2011;46:920-4.">Szary 2011</a>, and <a href="./references#CD013176-bbs2-0084" title="TheivanayagamS , LimRG , CobellWJ , GowdaJT , MattesonML , ChoudharyA , et al. Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. Saudi Journal of Gastroenterology2013;19(5):205-10.">Theivanayagam 2013</a> included a study with an unclear design (<a href="./references#CD013176-bbs2-0025" title="RudzkiS , CzekalowskiS , MichalakK , KuszW , FularzA . Erythromycin improves quality of endoscopy for acute upper gastrointestinal bleeding [Erytromycyna jako czynnik poprawiajacy jakość badania endoskopowego w ostrych krwawieniach z górnego odcinka przewodu pokarmowego]. Wiadomości Lekarskie2006;59:490-1. ">Rudzki 2006</a>). </p> <p>Four reviews analysed risk of bias using less accurate tools (<a href="./references#CD013176-bbs2-0030" title="BaiY , GuoJF , LiZS . Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding. Alimentary Pharmacology and Therapeutics2011;34:166-71.">Bai 2011</a> used "empirical evidence"; and <a href="./references#CD013176-bbs2-0031" title="BarkunAN , BardouM , MartelM , GralnekIM , SungJJ . Prokinetics in acute upper GI bleeding: a meta-analysis. Gastrointestinal Endoscopy2010;72(6):1138-45.">Barkun 2010</a>, <a href="./references#CD013176-bbs2-0082" title="SzaryNM , GuptaR , ChoudharyA , MattesonML , ArifM , HammadTH , et al. Erythromycin prior to endoscopy in acute upper gastrointestinal bleeding: a meta-analysis. Scandinavian Journal of Gastroenterology2011;46:920-4.">Szary 2011</a>, and <a href="./references#CD013176-bbs2-0084" title="TheivanayagamS , LimRG , CobellWJ , GowdaJT , MattesonML , ChoudharyA , et al. Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. Saudi Journal of Gastroenterology2013;19(5):205-10.">Theivanayagam 2013</a> used the Jadad scoring system). Only <a href="./references#CD013176-bbs2-0048" title="GuixiangS , JunW , FangT , YaoL , YoupingL , AiqingW . The effect of acute variceal bleeding interventions on reducing the requirement of blood transfusions in cirrhotic patients: a systematic review. International Journal of Clinical and Experimental Medicine2016;9(3):6166-77.">Guixiang 2016</a> and <a href="./references#CD013176-bbs2-0074" title="RahmanR , NguyenDL , SohailU , AlmashhrawiAA , AshrafI , PuliSR , et al. Pre-endoscopic erythromycin administration in upper gastrointestinal bleeding: an updated meta-analysis and systematic review. Annals of Gastroenterology2016;29:312-7.">Rahman 2016</a> used RoB 1. </p> <p>All previous reviews combined studies with different comparisons in the same analysis for all reported outcomes, and all reviews included primary outcomes that were not focused on participants, such as visualisation of gastric mucosa and need for second‐look endoscopy. </p> <p>Regarding the most frequently reported outcome (visualisation of gastric mucosa), all previous reviews reported a better visualisation of the gastric mucosa in the erythromycin group. However, they combined different comparators, and did not specify which visualisation scales were addressed, nor how they were combined. </p> <p>No previous reviews distinguished between participants with non‐variceal haemorrhage and those with variceal haemorrhage. <a href="./references#CD013176-bbs2-0048" title="GuixiangS , JunW , FangT , YaoL , YoupingL , AiqingW . The effect of acute variceal bleeding interventions on reducing the requirement of blood transfusions in cirrhotic patients: a systematic review. International Journal of Clinical and Experimental Medicine2016;9(3):6166-77.">Guixiang 2016</a> included only RCTs with cirrhotic participants. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD013176-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD013176-fig-0001" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD013176-fig-0002" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study. Empty spaces mean the study did not assess the outcome." data-id="CD013176-fig-0003" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. Empty spaces mean the study did not assess the outcome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Erythromycin versus placebo, Outcome 1: Serious adverse events" data-id="CD013176-fig-0004" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Erythromycin versus placebo, Outcome 1: Serious adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Erythromycin versus placebo, Outcome 2: All‐cause mortality" data-id="CD013176-fig-0005" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Erythromycin versus placebo, Outcome 2: All‐cause mortality</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Erythromycin versus placebo, Outcome 3: Visualisation of gastric mucosa (mean endoscopic score)" data-id="CD013176-fig-0006" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Erythromycin versus placebo, Outcome 3: Visualisation of gastric mucosa (mean endoscopic score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Erythromycin versus placebo, Outcome 4: Visualisation of gastric mucosa (empty stomach yes/no)" data-id="CD013176-fig-0007" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Erythromycin versus placebo, Outcome 4: Visualisation of gastric mucosa (empty stomach yes/no) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Erythromycin versus placebo, Outcome 5: Non‐serious adverse events" data-id="CD013176-fig-0008" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Erythromycin versus placebo, Outcome 5: Non‐serious adverse events</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Erythromycin versus placebo, Outcome 6: Rebleeding" data-id="CD013176-fig-0009" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Erythromycin versus placebo, Outcome 6: Rebleeding</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Erythromycin versus placebo, Outcome 7: Blood transfusion" data-id="CD013176-fig-0010" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Erythromycin versus placebo, Outcome 7: Blood transfusion</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Erythromycin versus placebo, Outcome 8: Rescue invasive intervention" data-id="CD013176-fig-0011" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: Erythromycin versus placebo, Outcome 8: Rescue invasive intervention</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage, Outcome 1: All‐cause mortality" data-id="CD013176-fig-0012" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage, Outcome 1: All‐cause mortality </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage, Outcome 2: Visualisation of gastric mucosa (mean endoscopic score)" data-id="CD013176-fig-0013" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage, Outcome 2: Visualisation of gastric mucosa (mean endoscopic score) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage, Outcome 3: Visualisation of gastric mucosa (empty stomach yes/no)" data-id="CD013176-fig-0014" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage, Outcome 3: Visualisation of gastric mucosa (empty stomach yes/no) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage, Outcome 4: Non‐serious adverse events" data-id="CD013176-fig-0015" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage, Outcome 4: Non‐serious adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage, Outcome 5: Rebleeding" data-id="CD013176-fig-0016" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage, Outcome 5: Rebleeding </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage, Outcome 6: Blood transfusion" data-id="CD013176-fig-0017" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage, Outcome 6: Blood transfusion </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage, Outcome 7: Rescue invasive intervention" data-id="CD013176-fig-0018" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage, Outcome 7: Rescue invasive intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Erythromycin versus nasogastric tube lavage, Outcome 1: All‐cause mortality" data-id="CD013176-fig-0019" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Erythromycin versus nasogastric tube lavage, Outcome 1: All‐cause mortality</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Erythromycin versus nasogastric tube lavage, Outcome 2: Visualisation of gastric mucosa (empty stomach yes/no)" data-id="CD013176-fig-0020" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Erythromycin versus nasogastric tube lavage, Outcome 2: Visualisation of gastric mucosa (empty stomach yes/no) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Erythromycin versus nasogastric tube lavage, Outcome 3: Non‐serious adverse events" data-id="CD013176-fig-0021" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Erythromycin versus nasogastric tube lavage, Outcome 3: Non‐serious adverse events </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Erythromycin versus nasogastric tube lavage, Outcome 4: Rebleeding" data-id="CD013176-fig-0022" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Erythromycin versus nasogastric tube lavage, Outcome 4: Rebleeding</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Erythromycin versus nasogastric tube lavage, Outcome 5: Rescue invasive intervention" data-id="CD013176-fig-0023" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Erythromycin versus nasogastric tube lavage, Outcome 5: Rescue invasive intervention </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD013176-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/urn:x-wiley:14651858:media:CD013176:CD013176-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Erythromycin plus nasogastric lavage versus metoclopramide plus nasogastric lavage, Outcome 1: Visualisation of gastric mucosa (empty stomach yes/no)" data-id="CD013176-fig-0024" src="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_t/tCD013176-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Erythromycin plus nasogastric lavage versus metoclopramide plus nasogastric lavage, Outcome 1: Visualisation of gastric mucosa (empty stomach yes/no) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/media/CDSR/CD013176/image_n/nCD013176-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD013176-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Erythromycin versus placebo for acute upper gastrointestinal haemorrhage</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Erythromycin versus placebo for acute UGIH</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with acute UGIH<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> erythromycin<br/><b>Comparison:</b> placebo </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with placebo</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with erythromycin</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UGIH‐related mortality</p> <p>Assessed with: number of deaths related to UGIH</p> <p>Follow‐up: 1 week (short term)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events reported in either group. <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> did not report follow‐up duration for UGIH‐related mortality assessment. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> assessed UGIH‐related mortality within 1 week of initial endoscopy. <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> assessed UGIH‐related mortality within 24 hours of initial endoscopy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SAEs</b><br/>Assessed with: number of participants experiencing at least 1 SAE </p> <p>Follow‐up: 1 week (short term)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 100<br/>(0 to 4) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD −0.01</b><br/>(−0.04 to 0.02) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> did not report follow‐up duration for SAE assessment. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> assessed SAEs within 1 week of initial endoscopy. <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> assessed SAEs during or just after initial endoscopy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Assessed with: number of deaths by any cause<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>6 per 100<br/>(3 to 9) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD 0.00</b><br/>(−0.03 to 0.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> did not report the follow‐up duration for all‐cause mortality assessment. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> assessed all‐cause mortality within 1 week of initial endoscopy. <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> assessed all‐cause mortality within 24 hours of initial endoscopy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Visualisation of gastric mucosa</b><br/>Assessed with: ordinal scale of 0–16 (higher is better) </p> <p>Follow‐up: NA</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 3.63 points higher</b><br/>(2.2 higher to 5.05 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>195<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>We standardised the 2 studies that applied ordinal scales of different boundaries (0–16 in <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>, 0–8 in <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAEs</b><br/>Assessed with: number of participants experiencing at least 1 NSAE<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>1 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>2 per 100<br/>(0 to 6) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD 0.01</b><br/>(−0.03 to 0.05) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> did not report the follow‐up duration for NSAE assessment. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> reported NSAEs within 1 week of initial endoscopy. <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> reported NSAEs after intervention infusion. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rebleeding</b> <br/>Assessed with: number of participants experiencing rebleeding<br/>Follow‐up: 1 day (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 100<br/>(1 to 21) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.63</b><br/>(0.13 to 2.90) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>195<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Study authors did not report rebleeding beyond 24 hours after initial endoscopy.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Blood transfusion</b><br/>Assessed with: number of packs of red blood cells transfused (standard unit of blood)<br/>Follow‐up: 1 day (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.44 units lower</b><br/>(0.86 to 0.01 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low</b><sup>b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit of measurement was standard unit of blood as defined by study authors. Only <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> reported the volume of each blood pack (250 mL–275 mL). <a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a> did not report follow‐up duration for blood transfusion assessment. <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> and <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> did not report blood transfusion beyond 24 hours after initial endoscopy.  </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>*The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>NA:</b> not applicable; <b>NSAE:</b> non‐serious adverse event; <b>RCT:</b> randomised clinical trial; <b>RD:</b> risk difference; <b>RR:</b> risk ratio; <b>SAE:</b> serious adverse event; <b>UGIH:</b> upper gastrointestinal haemorrhage. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for imprecision (no events reported in either group).<br/><sup>b</sup>Downgraded one level for risk of bias (unclear risk of attrition and reporting bias).<br/><sup>c</sup>Downgraded two levels for imprecision (very sparse data).<br/><sup>d</sup>Downgraded one level for imprecision (small sample size). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Erythromycin versus placebo for acute upper gastrointestinal haemorrhage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013176-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Erythromycin plus nasogastric tube lavage versus no intervention/placebo plus nasogastric tube lavage for acute upper gastrointestinal haemorrhage</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Erythromycin plus nasogastric tube lavage versus no intervention/placebo plus nasogastric tube lavage for acute UGIH</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with acute UGIH<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> erythromycin plus nasogastric tube lavage<br/><b>Comparison:</b> no intervention/placebo plus nasogastric tube lavage </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with no intervention/ placebo plus nasogastric tube lavage</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with erythromycin plus nasogastric tube lavage</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UGIH‐related mortality</p> <p>Assessed with: number of deaths related to UGIH<br/>Follow‐up: 30 days (long term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events reported in either group.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SAEs</b><br/>Assessed with: number of participants experiencing at least 1 SAE<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>408<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events reported in either group. <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed SAEs within 1 week and 30 days of initial endoscopy. 4 RCTs did not report follow‐up duration (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Assessed with: number of deaths by any cause<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3 per 100<br/>(0 to 8) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD −0.02</b><br/>(−0.08 to 0.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>238<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a> assessed all‐cause mortality within 48 hours of initial endoscopy. <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed all‐cause mortality within 1 week of initial endoscopy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Visualisation of gastric mucosa</b><br/>Assessed with: ordinal scale from 0–10 (higher is better)<br/>Follow‐up: NA </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SMD 0.48 points higher</b><br/>(0.10 higher to 0.85 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>170<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Studies applied ordinal scales of different boundaries (0–3 in <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a> and <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; 0–10 in <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAEs</b><br/>Assessed with: number of participants experiencing at least one NSAE<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>16 per 100<br/>(11 to 21) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD 0.00</b><br/>(−0.05 to 0.05) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>408<br/>(6 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed NSAEs within 1 week and 30 days from initial endoscopy. 4 RCTs did not report follow‐up duration (<a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rebleeding</b><br/>Assessed with: number of participants experiencing rebleeding<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 100<br/>(13 to 40) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.13</b><br/>(0.63 to 2.02) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>169<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Blood transfusion</b><br/>Assessed with: number of packs of red blood cells transfused (standard unit of blood)<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MD 1.85 units lower</b><br/>(4.34 lower to 0.64 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>180<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,d,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unit of measurement was a standard unit of blood as defined by study authors (no studies reported the volume of each blood pack). <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a> and <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a> assessed blood transfusion within 48 hours of initial endoscopy. <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a> assessed blood transfusion within 24 hours of initial endoscopy. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>NA:</b> not applicable; <b>NSAE:</b> non‐serious adverse event; <b>RCT:</b> randomised clinical trial; <b>RD:</b> risk difference; <b>RR:</b> risk ratio; <b>SAE:</b> serious adverse event; <b>SMD:</b> standardised mean difference; <b>UGIH:</b> upper gastrointestinal haemorrhage. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for risk of bias (high risk of performance bias).<br/><sup>b</sup>Downgraded two levels for imprecision (no events reported in either group).<br/><sup>c</sup>Downgraded two levels for imprecision (very sparse data).<br/><sup>d</sup>Downgraded one level for imprecision (small sample size).<br/><sup>e</sup>Downgraded two levels for inconsistency (high heterogeneity). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Erythromycin plus nasogastric tube lavage versus no intervention/placebo plus nasogastric tube lavage for acute upper gastrointestinal haemorrhage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013176-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Erythromycin compared to nasogastric tube lavage for acute upper gastrointestinal haemorrhage</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Erythromycin compared to nasogastric tube lavage for acute UGIH</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with acute UGIH<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> erythromycin<br/><b>Comparison:</b> nasogastric tube lavage </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with nasogastric tube lavage</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with erythromycin</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UGIH‐related mortality</p> <p>Assessed with: number of deaths related to UGIH<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>44<br/>(2 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events reported in either group. <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> assessed UGIH‐related mortality within one week and 30 days of initial endoscopy. <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> did not report follow‐up duration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SAEs</b><br/>Assessed with: number of participants experiencing at least 1 SAE<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>213<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b </sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events reported in either group. <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed SAEs within one week and 30 days of initial endoscopy. <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> did not report follow‐up duration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> <p>Assessed with: number of deaths by any cause<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>5 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>7 per 100<br/>(0 to 13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD 0.02</b><br/>(−0.05 to 0.08) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>213<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed all‐cause mortality within one week and 30 days of initial endoscopy. <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> did not report follow‐up duration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Visualisation of gastric mucosa</b><br/>Assessed with: number of participants scoring ≥ 6 points on an 8‐point scale </p> <p>Follow‐up: NA</p> <p> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>79 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>94 per 100 (62 to 100)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.19</b><br/>(0.79 to 1.79) </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>198<br/>(2 RCTs) </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAEs</b><br/>Assessed with: number of participants experiencing at least 1 NSAE<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>12 per 100 (0 to 35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RD −0.10</b><br/>(−0.34 to 0.13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>213<br/>(3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c,d </sup><br/>  </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a> and <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> assessed NSAEs within one week and 30 days of initial endoscopy. <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> did not report follow‐up duration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rebleeding</b><br/>Assessed with: number of participants experiencing rebleeding<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>20 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>15 per 100<br/>(8 to 30) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.77</b><br/>(0.40 to 1.49) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>169<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Blood transfusion</b><br/>Assessed with: number of packs of red blood cells transfused (standard unit of blood)<br/>Follow‐up: 1 week (short term) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> <p> </p> <p> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>169</p> <p>(1 RCT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,e</sup> </p> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The unit of measurement was a standard unit of blood as defined by the study authors (<a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> did not report the volume of each blood pack). <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a> provided only median and IQR (median 2, IQR 0–4 in the erythromycin group; median 2, IQR 0–4 in nasogastric tube lavage group). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>IQR:</b> interquartile range; <b>NA:</b> not applicable; <b>NSAE:</b> non‐serious adverse event; <b>RCT:</b> randomised clinical trial; <b>RD:</b> risk difference; <b>RR:</b> risk ratio; <b>SAE:</b> serious adverse event; <b>UGIH:</b> upper gastrointestinal haemorrhage. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for risk of bias (high risk of blinding of participants and personnel, blinding of outcome assessment and selective reporting).<br/><sup>b</sup>Downgraded two levels for imprecision (no events reported in either group).<br/><sup>c</sup>Downgraded two levels for imprecision (very sparse data).<br/><sup>d</sup>Downgraded two levels for inconsistency (high heterogeneity).<br/><sup>e</sup>Downgraded one level for imprecision (small sample size). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Erythromycin compared to nasogastric tube lavage for acute upper gastrointestinal haemorrhage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD013176-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Erythromycin plus nasogastric tube lavage compared to metoclopramide plus nasogastric tube lavage for acute upper gastrointestinal haemorrhage</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Erythromycin plus nasogastric tube lavage compared to metoclopramide plus nasogastric tube lavage for acute UGIH</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> people with acute UGIH<br/><b>Setting:</b> hospital<br/><b>Intervention:</b> erythromycin plus nasogastric tube lavage<br/><b>Comparison:</b> metoclopramide plus nasogastric tube lavage </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="top"> <p><b>Anticipated absolute effects* (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>№ of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with metoclopramide plus nasogastric tube lavage</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Risk with erythromycin plus nasogastric tube lavage</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>UGIH‐related mortality</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies measured UGIH‐related mortality.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>SAEs</b><br/>Assessed with: number of participants experiencing at least 1 SAE </p> <p>Follow‐up: not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events reported in either group. <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> did not report follow‐up duration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies measured all‐cause mortality.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Visualisation of gastric mucosa</b><br/>Assessed with: endoscopist opinion (gastric mucosa entirely visualised yes or no) </p> <p>Follow‐up: NA</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>67 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>87 per 100<br/>(57 to 100) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.30</b><br/>(0.86 to 1.96) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>NSAEs</b><br/>Assessed with: number of participants experiencing at least 1 NSAE </p> <p>Follow‐up: not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No events reported in either group. <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> did not report follow‐up duration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Rebleeding</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No studies measured rebleeding.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Blood transfusion</b><br/>Assessed with: number of packs of red blood cells transfused (standard unit of blood) </p> <p>Follow‐up: not reported</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> reported a mean of 2.26 (SD not reported) units of blood transfusion in the erythromycin plus nasogastric tube lavage group and 3.66 (SD not reported) in metoclopramide plus nasogastric tube lavage group. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<br/>(1 RCT) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very low</b><sup>a,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> did not report follow‐up duration. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% CI) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>NA:</b> not applicable; <b>NSAE:</b> non‐serious adverse event; <b>RCT:</b> randomised clinical trial; <b>RR:</b> risk ratio; <b>SAE:</b> serious adverse event; <b>SD:</b> standard deviation; <b>UGIH:</b> upper gastrointestinal haemorrhage. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup>Downgraded two levels for risk of bias (unclear risk for all domains).<br/><sup>b</sup>Downgraded two levels for imprecision (no events reported in either group).<br/><sup>c</sup>Downgraded two levels for imprecision (very sparse data).<br/><sup>d</sup>Downgraded two levels for imprecision (small sample size and 95% CI not computed due to missing SDs). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Erythromycin plus nasogastric tube lavage compared to metoclopramide plus nasogastric tube lavage for acute upper gastrointestinal haemorrhage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD013176-tbl-0005"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Agreements and disagreements among reviews</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Review</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Included RCTs</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Main outcomes</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0030" title="BaiY , GuoJF , LiZS . Meta-analysis: erythromycin before endoscopy for acute upper gastrointestinal bleeding. Alimentary Pharmacology and Therapeutics2011;34:166-71.">Bai 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Erythromycin versus control in UGIH (2 trials used nasogastric tube with gastric lavage before erythromycin infusion, and 2 trials did not allow nasogastric tube with gastric lavage). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013176-list-0024"> <li> <p>UGIH‐related mortality: not assessed</p> </li> <li> <p>SAEs: not assessed</p> </li> <li> <p>All‐cause mortality: lower in erythromycin group (RR 0.51, 95% CI 0.17 to 1.52, P = 0.23), although 95% CI crossed line of no effect </p> </li> <li> <p>Visualisation of gastric mucosa: improved in erythromycin group (RR 1.90, 95% CI 1.53 to 2.37, P &lt; 0.001) </p> </li> <li> <p>Blood transfusion: reduced in erythromycin group (MD −0.51, 95% CI −0.95 to −0.07, P = 0.02) </p> </li> <li> <p>Rescue invasive intervention: not assessed</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0031" title="BarkunAN , BardouM , MartelM , GralnekIM , SungJJ . Prokinetics in acute upper GI bleeding: a meta-analysis. Gastrointestinal Endoscopy2010;72(6):1138-45.">Barkun 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Erythromycin and metoclopramide versus placebo or no treatment in UGIH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs that used erythromycin as an intervention: <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013176-list-0025"> <li> <p>UGIH‐related mortality: not assessed</p> </li> <li> <p>SAEs: not assessed</p> </li> <li> <p>All‐cause mortality: not assessed</p> </li> <li> <p>Visualisation of gastric mucosa: endoscopic visualisation not analysed because disparate definitions across studies prevented meaningful clinical inferences </p> </li> <li> <p>Blood transfusion: not significantly reduced in erythromycin group versus placebo group (WMD −0.98, 95% CI −2.81 to 0.85) and no treatment (WMD −0.48, 95% CI −0.97 to 0.01) </p> </li> <li> <p>Rescue invasive intervention: need for surgery not significantly reduced in erythromycin group (OR 1.11, 95% CI 0.27 to 4.67) </p> </li> </ul> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0048" title="GuixiangS , JunW , FangT , YaoL , YoupingL , AiqingW . The effect of acute variceal bleeding interventions on reducing the requirement of blood transfusions in cirrhotic patients: a systematic review. International Journal of Clinical and Experimental Medicine2016;9(3):6166-77.">Guixiang 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Any intervention versus any control for management of variceal bleeding in people with liver cirrhosis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RCTs that used erythromycin as an intervention: <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013176-list-0026"> <li> <p>UGIH‐related mortality: not assessed</p> </li> <li> <p>SAEs: not assessed</p> </li> <li> <p>All‐cause mortality: not assessed</p> </li> <li> <p>Visualisation of gastric mucosa: not assessed</p> </li> <li> <p>Blood transfusion: data from <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a> only (no difference between groups) </p> </li> <li> <p>Rescue invasive intervention: not assessed</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0074" title="RahmanR , NguyenDL , SohailU , AlmashhrawiAA , AshrafI , PuliSR , et al. Pre-endoscopic erythromycin administration in upper gastrointestinal bleeding: an updated meta-analysis and systematic review. Annals of Gastroenterology2016;29:312-7.">Rahman 2016</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Erythromycin before endoscopy versus no erythromycin or placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0025" title="RudzkiS , CzekalowskiS , MichalakK , KuszW , FularzA . Erythromycin improves quality of endoscopy for acute upper gastrointestinal bleeding [Erytromycyna jako czynnik poprawiajacy jakość badania endoskopowego w ostrych krwawieniach z górnego odcinka przewodu pokarmowego]. Wiadomości Lekarskie2006;59:490-1. ">Rudzki 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013176-list-0027"> <li> <p>UGIH‐related mortality: not assessed</p> </li> <li> <p>SAEs: not assessed</p> </li> <li> <p>All‐cause mortality: not assessed</p> </li> <li> <p>Visualisation of gastric mucosa: higher frequency of adequate gastric mucosa visualisation in erythromycin group (OR 4.14, 95% CI 2.01 to 8.53, P &lt; 0.01) </p> </li> <li> <p>Blood transfusion: no clear difference between erythromycin and no erythromycin in amount of blood transfusions required (MD −1.06, 95% CI − 2.24 to 0.13, P = 0.08). After exclusion of <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>, amount of blood transfusions was lower in erythromycin group (MD −0.41, 95% CI −0.82 to −0.01, P = 0.04). </p> </li> <li> <p>Rescue invasive intervention: no difference in need for emergency surgery (OR 1.11, 95% CI 0.27 to 4.67, P = 0.88) </p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0082" title="SzaryNM , GuptaR , ChoudharyA , MattesonML , ArifM , HammadTH , et al. Erythromycin prior to endoscopy in acute upper gastrointestinal bleeding: a meta-analysis. Scandinavian Journal of Gastroenterology2011;46:920-4.">Szary 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Erythromycin infusion versus no erythromycin in UGIH</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0025" title="RudzkiS , CzekalowskiS , MichalakK , KuszW , FularzA . Erythromycin improves quality of endoscopy for acute upper gastrointestinal bleeding [Erytromycyna jako czynnik poprawiajacy jakość badania endoskopowego w ostrych krwawieniach z górnego odcinka przewodu pokarmowego]. Wiadomości Lekarskie2006;59:490-1. ">Rudzki 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013176-list-0028"> <li> <p>UGIH‐related mortality: not assessed</p> </li> <li> <p>SAEs: not assessed</p> </li> <li> <p>All‐cause mortality: not assessed</p> </li> <li> <p>Visualisation of gastric mucosa: improved in erythromycin group (OR 4.89, 95% CI 2.85 to 8.38, P &lt; 0.01) </p> </li> <li> <p>Blood transfusion: fewer units of blood transfused in erythromycin group (WMD −0.48, 95% CI −0.97 to 0.01, P = 0.05), though 95% CI included no effect </p> </li> <li> <p>Rescue invasive intervention: not assessed</p> </li> </ul> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0084" title="TheivanayagamS , LimRG , CobellWJ , GowdaJT , MattesonML , ChoudharyA , et al. Administration of erythromycin before endoscopy in upper gastrointestinal bleeding: a meta-analysis of randomized controlled trials. Saudi Journal of Gastroenterology2013;19(5):205-10.">Theivanayagam 2013</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Erythromycin versus no erythromycin in UGIH (RCTs that performed nasogastric lavage on only 1 group were excluded) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0025" title="RudzkiS , CzekalowskiS , MichalakK , KuszW , FularzA . Erythromycin improves quality of endoscopy for acute upper gastrointestinal bleeding [Erytromycyna jako czynnik poprawiajacy jakość badania endoskopowego w ostrych krwawieniach z górnego odcinka przewodu pokarmowego]. Wiadomości Lekarskie2006;59:490-1. ">Rudzki 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013176-list-0029"> <li> <p>UGIH‐related mortality: not assessed</p> </li> <li> <p>SAEs: not assessed</p> </li> <li> <p>All‐cause mortality: not assessed</p> </li> <li> <p>Visualisation of gastric mucosa: improved in erythromycin group (OR 3.43, 95% CI 1.81 to 6.50, P &lt; 0.01) </p> </li> <li> <p>Blood transfusion: need for blood transfusion reduced in erythromycin group (WMD −0.41, 95% CI −0.82 to −0.01, P = 0.04) </p> </li> <li> <p>Rescue invasive intervention: not assessed</p> </li> </ul> </p> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Adao 2022 (current review)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <ul id="CD013176-list-0030"> <li> <p>Erythromycin versus placebo</p> </li> <li> <p>Erythromycin plus nasogastric tube lavage versus no intervention/placebo plus nasogastric tube lavage </p> </li> <li> <p>Erythromycin versus nasogastric tube lavage</p> </li> <li> <p>Erythromycin plus nasogastric tube lavage versus metoclopramide plus nasogastric tube lavage </p> </li> </ul> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD013176-bbs2-0001" title="Ali ShahSA , NadeemM , JameelM , YasminR , AfsarA , RiazF . Oral erythromycin improves the quality of endoscopy in upper gastrointestinal bleeding patients. Cureus2020;12(9):e10204. ">Ali Shah 2020</a>; <a href="./references#CD013176-bbs2-0002" title="AltraifI , HandooFA , AljumahA , AlalwanA , DafallaM , SaeedAM , et al. Effect of erythromycin before endoscopy in patients presenting with variceal bleeding: a prospective, randomized, double blind, placebo-controlled trial. Gastrointestinal Endoscopy2011;73(2):245-50. AltraifI . Effect of intravenous bolus infusion of erythromycin prior to endoscopy in patients presenting with variceal bleeding: a prospective, randomized, placebo controlled, double blind trial. In: Hepatology. Vol. 50. 2009:402A. AltraifI . Information for Cochrane Review [personal communication]. Email to: D Adão 24 March 2020. ">Altraif 2011</a>; <a href="./references#CD013176-bbs2-0003" title="ArdakaniMJ , ZareE , BasiriM , ShalmaniHM . Erythromycin decreases the time and improves the quality of EGD in patients with acute upper GI bleeding. Gastroenterology and Hepatology from Bed to Bench2013;6(4):195-201. ">Ardakani 2013</a>; <a href="./references#CD013176-bbs2-0004" title="CarbonellN , BecquemontL , BoellePY , DaguenelA , GodardV , SerfatyL , et al. IV erythromycin improves gastric lavage in acute upper gastrointestinal bleeding: a randomized controlled trial [L'érythromycine intraveineuse améliore le lavage gastrique au cours de l'hémorragie digestive haute: essai prospectif, controlé, randomisé]. In: Journées Francophones d’Hépato-Gastroentérologie et d’Oncologie Digestive. 2005. CarbonellN , PauwelsA , SerfatyL , BoellePY , BecquemontL , PouponR . Erythromycin infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. American Journal of Gastroenterology2006;101(6):1211-5. ">Carbonell 2006</a>; <a href="./references#CD013176-bbs2-0005" title="CoffinB , PocardM , PanisY , RicheF , LainéMJ , BitounA , et al. Erythromycin improves the quality of EGD in patients with acute upper GI bleeding: a randomized controlled study. Gastrointestinal Endoscopy2002;56(2):174-9. ">Coffin 2002</a>; <a href="./references#CD013176-bbs2-0006" title="FrossardJL , SpahrL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. Erythromycin intravenous bolus infusion in acute upper gastrointestinal bleeding: a randomized, controlled, double-blind trial. Gastroenterology2002;123(1):17-23. Erratum in: Gastroenterology 2002 Dec;123(6):2162-3. SpahrL , FrossardJL , QueneauPE , GiostraE , BurckhardtB , OryG , et al. IV erythromycin improves the diagnostic performance of endoscopy in acute upper GI bleeding: a randomized controlled trial. In: Hepatology. Vol. 34. 2001:343A. ">Frossard 2002</a>; <a href="./references#CD013176-bbs2-0007" title="GuardiolaJ , BotarguesJM , BerrozpeA , PonsC , Rodriguez-MorantaF , Soriano-IzquierdoA . Gastric lavages versus intravenous erythromycin prior to urgent endoscopy for acute upper gastrointestinal bleeding: a randomized trial – preliminary results. Gastrointestinal Endoscopy2009;69(5):AB186-7. ">Guardiola 2009</a>; <a href="./references#CD013176-bbs2-0008" title="HabashiSL , LambiaseLR , KottoorR . Prokinetics infusion prior to endoscopy for acute upper gastrointestinal bleeding: a randomized, controlled, double-blind &amp; placebo-controlled trial. In: American Journal of Gastroenterology. Vol. 102. 2007:S526. ">Habashi 2007</a>; <a href="./references#CD013176-bbs2-0009" title="NaHK , JungHY , SeoDW , LimH , AhnJY , LeeJH , et al. Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial. Korean Journal of Internal Medicine2017;32(6):1002-9. ">Na 2017</a>; <a href="./references#CD013176-bbs2-0010" title="PateronD , VicautE , DebucE , SahraouiK , CarbonellN , BobbiaX , et al. Erythromycin infusion or gastric lavage for upper gastrointestinal bleeding: a multicenter randomized controlled trial. Annals of Emergency Medicine2011;57(6):582-9. ">Pateron 2011</a>; <a href="./references#CD013176-bbs2-0011" title="SearsRJ , DuckworthC , BalabanDH , HanKH , GoldinGF , OelsnerDH , et al. Erythromycin versus gastric lavage for pre-endoscopic preparation of patients with upper gastrointestinal bleeding. Gastrointestinal Endoscopy1996;43(4):358. ">Sears 1996</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For the comparison erythromycin versus placebo:</p> <p> <ul id="CD013176-list-0031"> <li> <p>UGIH‐related mortality: no UGIH‐related deaths in either group</p> </li> <li> <p>SAEs: evidence is very uncertain (RD −0.01, 95% CI −0.04 to 0.02).</p> </li> <li> <p>All‐cause mortality: evidence is very uncertain (RD −0.00, 95% CI −0.03 to 0.03).</p> </li> <li> <p>Visualisation of gastric mucosa: erythromycin may increase visualisation of gastric mucosa (MD 3.63, 95% CI 2.2 to 5.05). </p> </li> <li> <p>Blood transfusion: erythromycin may result in a slight reduction in blood transfusion (MD −0.44, 95% CI −0.86 to −0.01). </p> </li> <li> <p>Rescue invasive intervention: evidence is very uncertain (RD 0.01, 95% CI −0.03 to 0.06). </p> </li> </ul> </p> <p> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>CI: confidence interval; MD: mean difference; OR: odds ratio; RD: risk difference; RR: risk ratio; SAE: serious adverse event; UGIH: upper gastrointestinal haemorrhage; WMD: weighted mean difference. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Agreements and disagreements among reviews</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/full#CD013176-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013176-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Erythromycin versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.04, 0.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.03, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Visualisation of gastric mucosa (mean endoscopic score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.63 [2.20, 5.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Visualisation of gastric mucosa (empty stomach yes/no) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 Judgement of endoscopist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.47 [1.66, 3.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Scale split</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>150</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.09 [1.44, 3.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Non‐serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.03, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Rebleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.13, 2.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Blood transfusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.44 [‐0.86, ‐0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 Rescue invasive intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.03, 0.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Erythromycin versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013176-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Short‐term follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.08, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Long‐term follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.12, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.3 Unknown follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.24, 0.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Visualisation of gastric mucosa (mean endoscopic score) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.48 [0.10, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Visualisation of gastric mucosa (empty stomach yes/no) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Judgement of endoscopist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.96, 2.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Scale split</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.33 [0.95, 1.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Non‐serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>408</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.00 [‐0.05, 0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Rebleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Short‐term follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.63, 2.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.2 Long‐term follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.61, 1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Blood transfusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.85 [‐4.34, 0.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Rescue invasive intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.38 [0.06, 2.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Erythromycin plus nasogastric tube lavage versus no treatment/placebo plus nasogastric tube lavage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013176-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Erythromycin versus nasogastric tube lavage</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Short‐term follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.05, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 Long‐term follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.07, 0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Visualisation of gastric mucosa (empty stomach yes/no) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Judgement of endoscopist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.89, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 Scale split</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.19 [0.79, 1.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Non‐serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>213</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Difference (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.34, 0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Rebleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.1 Short‐term follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.40, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4.2 Long‐term follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.61, 1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Rescue invasive intervention <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 Short‐term follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.04, 2.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.2 Long‐term follow‐up</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.02, 8.07]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Erythromycin versus nasogastric tube lavage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD013176-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Erythromycin plus nasogastric lavage versus metoclopramide plus nasogastric lavage</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Visualisation of gastric mucosa (empty stomach yes/no) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Erythromycin plus nasogastric lavage versus metoclopramide plus nasogastric lavage</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD013176.pub2/references#CD013176-tbl-0009">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD013176.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD013176-note-0023">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD013176-note-0019">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD013176-note-0021">Français</a> </li> <li class="section-language"> <a class="" href="id#CD013176-note-0017">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ru#CD013176-note-0014">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD013176-note-0016">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD013176-note-0012">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013176\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013176\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013176\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD013176\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD013176\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=EBp84H4P&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013176.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD013176.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD013176.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD013176.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD013176.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728734092"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013176.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728734096"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD013176.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ecbb0b858f56f',t:'MTc0MDcyODczNC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 